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1. INTRODUCTION 
 
1.1.Drug delivery systems                                                                 ( Y.W Chien., 2009) 
  The advancement of pharmacokinetics has established that the drug should be 
present above a certain minimum concentration in blood for as long a period as possible 
for optimum drug therapy. 
Although, continuous infusion has been recognized as a superior mode of drug 
administration to maintain a constant and prolonged rug level in the body such mode of 
administration entails certain risk and hence requires hospitalization of the patient and 
close supervision. 
As a result, solid oral dosage forms have become the most important and mostly 
used class of drug delivery system. Ordinary tablet and capsules known as conventional 
drug delivery system have to be administered several times a day depending on the 
biological half-life of the drug.  Such multiple dosing may reduce invariably high plasma 
level of drug leading to waste of costly drugs and patient non-compliance. 
Two important features as important while developing as drug delivery system. 
i.e., it should deliver the drug at a rate dictated by the needs of the body over the entire 
period of treatment and the drug should solely reach the site of action. 
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1.2.Sustained drug delivery systems                                            (N.K.Jain., 2008) 
The recognition of the fact that the absorption rate of the drugs into the body can 
be decreased by reduction of the rate of release of drug from the dosage forms.  It leads to 
develop some system to release their medications to the body slowly for prolonged drug 
release and sustained drug action. 
Current efforts in the area of drug delivery include the development of targeted 
delivery in which the drug in only active in the body (for example, in cancerous tissues) 
and sustained release formulations which the drug is released over a period of time in a 
controlled manner form a formulation.  These of sustained release formulations include 
liposomes, drug loaded biodegradable microspheres and drug polymer conjugates. 
1. Improve patient’s compliance and convenience due to less frequent dosing of 
drug. 
2. Reduced ‘See-saw’ fluctuation and therefore helps in better control of disease 
condition. 
3. Maximum utilization drug enabling reduction in total amount of dose 
administered. 
4. Reduction in health care cost through improved therapy, shorter treatment period 
and less frequency of dosing. 
The problem frequently encountered is the is the increase the residence time of 
the dosage form in the stomach and proximal portion of the small intestine, due to the 
rapid gastrointestinal transit phenomenon of the stomach which may consequently 
diminish the extent of absorption of many drugs since almost most of the drug entities are 
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mostly absorbed from the upper part of the intestine, therefore it would be beneficial to 
develop a sustained release formulation which remain at the absorption site for an 
extended period of time. 
Several approaches have been immersed to prolong the residence time of the dosage 
forms at the absorption site and one of these is the development of oral 
bioadhesive/mucoadhesive system. Various gastrointestinal mucoadhesive dosage forms, 
such as discs, microspheres, and bilayered tablets, have been thoroughly prepared and 
reported by several research groups. 
1.3. Mucoadhesive drug delivery systems                            (Shobha rani., 2008) 
Mucoadhesive drug delivery system is a new system of drug delivery and has 
recently gained great concern in pharmaceutical sciences.  The concept of mucoadhesives 
was introduced in the early 1980s. Mucoadhesion can be defined as the phenomenon of 
the attachment of natural or synthetic polymers to a mucosal surface. In general, the 
process involved in the mucoadhesion phenomenon can be described in three steps: first 
of all, the wetting and swelling of the polymer should allow an intimate contact with the 
tissue and secondly, interpenetration of the polymer chains and entanglement between the 
polymer and the mucin chains should be attained and finally, the formation of weak 
chemical bonds. Mucus is a viscous and heterogeneous biological product that coats 
many epithelial surfaces. Mucus-secreting cells are widely spread in different locations in 
the body, including the nasal, ocular, buccal area and the gastrointestinal, reproductive 
and respiratory tracts. Mainly, the mucus serves as a lubricant to minimize shear stresses 
and as a protection barrier against harmful substances. However, mucus can perform 
other important functions. Goblet cells located in the epithelium are unicellular mucus-
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secreting glands. Mucus is stored in large granules in the goblet cell and can be released 
by exocytosis or exfoliation of the whole cell. Mucus granules are mainly stored in the 
apical side of the goblet cell, which results in the characteristic balloon shape of these 
cells. Although the secretion of mucus can vary depending on age, sex, body location and 
health condition, the average mucus turnover is approximately 6 h. Mucus consists 
mainly of water (up to 95% weight), inorganic salts (about 1% weight), carbohydrates 
and lipids (less than 1%) and glycoproteins (no more than 5% weight). Mucus 
glycoproteins are also called mucins and consist of a protein core with branched 
oligosaccharide chains attached over 63% of its length. Approximately 80% by weight of 
the glycoprotein consists of oligosaccharides, which make the mucin more hydrosoluble 
and also protects the protein core from proteolytic degradation  
 
Figure 1.1: Mucus layer on epithelial surface 
Bioadhesives are natural polymeric materials that act as adhesives. The term is 
sometimes used more loosely to describe glue formed synthetically from biological 
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monomers such as sugars, or to mean a synthetic material designed to adhere to 
biological tissue. The term bioadhesion refers to any bond formed between two biological 
surfaces or a bond between a biological and a synthetic surface. It may be defined as 
attachment of synthetic biological macromolecules to a biological tissue. A more specific 
term than bioadhesion is mucoadhesion. 
Mucoadhesion is the relatively new and emerging concept in drug delivery. 
Mucoadhesion is the special case of bioadhesion where the biological tissue is an 
epithelium covered by mucus. Most mucosal surfaces such as in the gut or nose are 
covered by a layer of mucus. 
Adhesion of a matter to this layer is hence called mucoadhesion. Mucoadhesion 
keeps the delivery system adhering to the mucus membrane.  
Mucoadhesion can be defined as the ability of synthetic or biological 
macromolecules to adhere to mucosal tissues. The concept of mucoadhesion is one that 
has the potential to improve the highly variable residence times experienced by drugs and 
dosage forms at various sites in the gastrointestinal tract, and consequently, to reduce 
variability and improve efficacy. 
These systems remain in close contact with the absorption tissue, the mucous 
membrane, releasing the drug at the site of action leading to an increase in bioavailability. 
Mucoadhesive drug delivery system prolong the residence time of the dosage 
form at the site of application or absorption and facilitate an intimate contact of the 
dosage form with the underline absorption surface and thus contribute to improved and / 
or better therapeutic performance of the drug. 
 The mucoadhesive drug delivery system may include the following 
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1. Buccal delivery system. 
2. Sublingual Delivery system. 
3. Vaginal delivery system. 
4. Rectal delivery system. 
5. Nasal delivery system. 
6. Ocular delivery system. 
7. Gastro Intestinal delivery system 
 
 
 
 
 
 
 
 
 
 
   
 
Figure 1.2. Potential sites for mucosal drug delivery 
Their ability to stick to mucous membranes attracted attention as a pathway for 
resolving the problem of low bioavailability of traditional delivery systems used in the 
oral cavity and on the surface of the eye or other organs where movement of tissues or 
production of various secretions prevents prolonged retention of the medicinal agent. The 
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reasons that the oral route achieved such popularity may be in part attributed to its ease of 
administration as well as the traditional belief that by oral administration the drug is well 
absorbed as the food stuffs that are ingested daily. 
In the exploration of oral controlled release drug administration, one encounters three 
areas of potential challenge. 
1. Development of a drug delivery system: To develop a viable oral controlled release 
drug delivery system capable of delivering a drug at a therapeutically effective rate to a 
desirable site for duration required for optimal treatment. 
2. Modulation of gastro intestinal transit time: To modulate the GI transit time so that 
the drug delivery system developed can be transported to a target site or to the vicinity of 
an absorption site and reside there for prolonged period of time to maximize the delivery 
of a drug dose. 
3. Minimization of hepatic first pass elimination: If the drug to be delivered is 
subjected to extensive hepatic first pass elimination, preventive measures should be 
devised to either bypass or minimize the extent of hepatic metabolic effect.  
Definition of mucoadhesion          (Amit Alexander., 2011) 
Adhesion can be defined as the bond produced by contact between a pressure - 
sensitive adhesive and a surface The American Society of testing and materials has 
defined it as the state in which two surfaces are held together by interfacial forces, which 
may consist of valence forces, interlocking action or both. When the adhesion involves 
mucus or mucus membrane it is termed as mucoadhesion.  
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Concepts of mucoadhesion  
In biological systems, four types of bioadhesion can be distinguished as follows:- 
1. Adhesion of a normal cell on another normal cell. 
2. Adhesion of a cell with a foreign substance. 
3. Adhesion of a normal cell to a pathological cell. 
4. .Adhesion of an adhesive to a biological substance.  
Mucous membrane 
Mucous membranes are the moist linings of the orifices and internal parts of the 
body that are in continuity with the external surface. They cover, protect, and provide 
secretory and absorptive functions in the channels and extended pockets of the outside 
world that are incorporated in the body. Mucus is a translucent and viscid secretion, 
which forms a thin, continuous gel blanket adherent to mucosal epithelial surface. The 
mean thickness of this layer varies from about 50-450 μm in humans. It is secreted by the 
goblet cells lining the epithelia or by special exocrine glands with mucus cells acini. The 
exact composition of the mucus layer varies substantially, depending on the species, the 
anatomical location and pathological states. They secrete a viscous fluid known as 
mucus, which acts as a protective barrier and also lubricates the mucosal membrane. 
Mucosal membranes of human organism are relatively permeable and allow fast drug 
absorption They are characterized by an epithelial layer whose surface is covered by 
mucus.  The primary constituent of mucus is a glycoprotein known as mucin as well as 
water and inorganic salts. However, it has general composition. 
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                   Table 1.1: Composition of Mucous Membrane 
S.NO. COMPOSITION % AMOUNT 
1 Water 95 
2 Glycoproteins & Lipids 0.5-5.0 
3 Mineral Salts 1 
4 Free Proteins 0.5-1.0 
+ 
Table 1.2: Comparative properties of gastrointestinal, Dermal and Transmucosal  
                   drug administration                     (Khar, et al., 2003)   
 
Gastrointestinal Dermal Nasal 
Oral 
mucosal 
Vaginal 
Accessibility + +++ ++ ++ + 
Surface area +++ +++ + ++ +++ 
Surface Environment + ++ ++ +++ + 
Permeability +++ + +++ ++ +++ 
Reactivity ++ ++ + +++ ++ 
Vascular Drainage +++ + +++ ++ +++ 
First pass clearance + +++ +++ +++ + 
Patient acceptability ++ +++ ++ +++ +++ 
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Examples of mucosa 
· Buccal mucosa. 
· Oesophageal mucosa. 
· Gastric mucosa. 
· Intestinal mucosa. 
· Nasal mucosa. 
· Olfactory mucosa. 
· Oral mucosa. 
· Bronchial mucosa. 
· Uterine mucosa. 
· Endometrium (mucosa of the uterus). 
· Penile mucosa. 
1.4 Mucoadhesive polymers 
Mucoadhesive polymers are water-soluble and water-insoluble polymers, which 
are swellable networks, jointed by cross-linking agents. These polymers possess optimal 
polarity to make sure that they permit sufficient wetting by the mucus and optimal 
fluidity that permits the mutual adsorption and interpenetration of polymer and mucus to 
take place.  
Mucoadhesive polymers that adhere to the musin-epithelial surface can be 
conveniently divided into three broad classes,  
1) Polymers that become sticky when placed in water and owe their muco- adhesion 
to stickiness. 
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2) Polymers that adhere through nonspecific, noncovalent interactions are primarily 
electrostatic in nature (although hydrogen and hydrophobic bonding may be 
significant). 
3) Polymers that bind to specific receptor site on tile self surface. 
Examples of some Mucoadhesive polymer 
Natural /Semi-synthetic   Na alginate,  Agarose,  Chitosan, 
                                           Pectin,   Tragacanth,  Gelatin, 
                                          Xanthan gum,  Carragenan,  Starch 
 
Synthetic       Poly vinyl alcohol,  Polyamides,       Polycarbonates, 
                      Poly alkylene glycols,  Poly vinyl ethers, Esters and halides 
              Poly methacrylic acid, PMMA,  Methyl cellulose, 
                        Ethyl cellulose,               HPC,   HPMC 
Methyl cellulose,   Sod. CMC 
 
Bicompatible                Esters of haluronic acid, 
                                       Polyvinyl acetate, 
                                       Ethylene glycol. 
 
Biodegradable  Poly (lactides),  Poly (lactide-coglycolides), 
Poly caprolactones, Poly alkyl cyanoacrylates. 
Poly orthoesters, Poly (glycolides), 
Poly phosphoesters, Poly anhydrides, 
Poly phosphazenes, Chitosan, 
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Ideal characteristics of a mucoadhesive polymer 
1. The polymer and its degradation products should be nontoxic and nonabsorable 
from the GIT. 
2. It should be nonirritant to the mucous membrane. 
3. It should preferably form a strong noncovalent bond with the mucin-epithelial cell 
surfaces. 
4. It should adhere quickly to most tissue and should possess some site-specificity. 
5. It should allow daily incorporation to the drug and offer no hindrance to its 
release. 
6. The polymer must not decompose on storage or during the shelf life of the dosage 
form. 
7. The cost of polymer should not be high so that the prepared dosage form remains 
competitive. 
1.5. Factors affecting mucoadhesion 
1) Polymer Related Factors  
a) Molecular weight: The interpenetration of polymer molecules into the mucus layer is 
variable, for low molecular weight polymers penetration is more than high molecular 
weight polymers because entanglements are favored in high molecular weight polymers. 
b) Concentration of active polymer: For solid dosage forms such as tablets, the higher 
the concentration of polymer, the stronger the bioadhesion force. 
c) Spatial Conformation: Bioadhesive force is also dependent on the conformation of 
polymers, i.e., helical or linear. The helical conformation of polymers may shield many 
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active groups, primarily responsible for adhesion, thus reducing the mucoadhesive 
strength of the polymer. 
d) Chain flexibility of polymer: Chain flexibility is important for interpenetration and 
enlargement. As water-soluble polymers become more and more cross linked, the 
mobility of the individual polymer chain decreases, also as the cross linking density 
increases, the effective length of the chain which can penetrate into mucus decrease even 
further and mucoadhesive strength is reduced. 
e) Degree of Hydration: Another important factor affecting the mucoadhesive strength 
of polymeric components is the degree of hydration. In this respect many polymers will 
exhibit adhesive properties under conditions where the amount of water is limited. 
However in such a situation, adhesion is thought to be a result of a combination of 
capillary attraction and osmotic forces between the dry polymer and the wet mucosal 
surface which act to dehydrate and strengthen the mucus layer. Although this kind of 
“sticking” has been referred to as mucoadhesion it is important to clearly distinguish such 
processes from “wet-on-wet” adhesion in which swollen mucoadhesive polymers attach 
to mucosal surfaces. Hydration is essential for the relaxation and interpenetration of 
polymer chains, excess hydration could lead to decreased mucoadhesion and/orientation 
due to the formation of slippery mucilage. In this situation cross linked polymers that 
only permit a certain degree of hydration may be advantageous for providing a prolonged 
mucoadhesive effect. The attachment and bonding of bioadhesive polymers to biological 
substrates occurs mainly through interpenetration followed by secondary non-covalent 
bonding between substrates. Given that secondary bonding mainly arises due to hydrogen 
bond formation, it is well accepted that mucoadhesive polymers possessing hydrophilic 
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functional such as, carboxyl (COOH), hydroxyl (OH), amide (NH2) and sulphate groups 
(SO4H) may be more favorable in formulating targeted drug delivery platforms. 
Typically, physical entanglements and secondary interactions (hydrogen bonds) 
contribute to the formation of a strengthened network; therefore polymers that exhibit a 
high density of available hydrogen bonding groups would be able to interact more 
strongly with mucin glycoproteins. 
2) Environmental – Related Factors  
a) pH: pH influences the charge on the surface of both mucus and polymers. Mucus will 
have a different charge density depending on pH, because of difference in dissociation of 
functional groups on carbohydrate moiety and amino acids of the polypeptide backbone, 
which may affect adhesion. 
b) Applied strength: To place a solid bioadhesive system, it is necessary to apply a 
defined strength. Whichever the polymer may be the adhesion strength of those polymers 
increases with the increase in the applied strength. 
c) Initial contact time: The initial contact time between mucoadhesive and the mucus 
layer determines the extent of swelling and the interpenetration of polymer chains. The 
mucoadhesive strength increases as the initial contact time increases. 
d) Selection of the model substrate surface: The handling and treatment of biological 
substrates during the testing of mucoadhesive is an important factor, since physical and 
biological changes may occurs in the mucus gels or tissues under the experimental 
conditions. 
3) Swelling: The swelling characteristic is related to the polymer itself, and also to its 
environment. Interpenetration of chains is easier as polymer chains are disentangled and 
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free of interactions. More the swelling of polymeric matrix higher the adhesion time of 
polymers. 
4) Physiological variables: 
Mucin turnover and disease state of mucus layer are physiological variables, 
which may affect bioadhesion. 
Functions of mucous layer                                                                   (N.K.Jain ., 1997) 
The mucous layer, which covers the epithelial surface, has various roles.  
1. Protective Role.  
2. Barrier Role.  
3. Adhesion Role.  
4. Lubrication Role. 
5. Mucoadhesion Role. 
1. Protective Role: The Protective role results particularly from its hydrophobicity and 
protecting the mucosa from the lumen diffusion of hydrochloric acid from the lumen to 
the epithelial surface.  
2. Barrier Role: The role of mucus layer as barrier in tissue absorption of drugs and 
other substances is well known as it influence the bioavailibity of the drugs.The mucus 
constitutes diffusion barrier for molecules, and especially against drug absorption 
diffusion through mucus layer depends on molecule charge, hydration radius, ability to 
form hydrogen bonds and molecular weight 
3. Adhesion Role: Mucus has strong cohesive properties and firmly binds the epithelial 
cells surface as a continuous gel layer.  
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4. Lubrication Role: An important role of the mucus layer is to keep the membrane 
moist. Continuous secretion of mucus from the goblet cells is necessary to compensate 
for the removal of the mucus layer due to digestion, bacterial degradation and 
solubilisation of mucin molecules 
5. Mucoadhesion Role: One of the most important factors for bioadhesion is tissue 
surface roughness. Adhesive joints may fail at relatively low applied stresses if cracks, air 
bubbles, voids, inclusions or other surface defects are present. Viscosity and wetting 
power are the most important factors for satisfactory bioadhesion.  
At physiological pH, the mucus network may carry a significant negative charge because 
of the presence of sialic acid and sulphate residues and this high charge density due to 
negative charge contributes significantly to the bioadhesion. 
Need of mucoadhesive 
¾ Controlled release. 
¾ Target & localised drug delivery. 
¾ By pass first pass metabolism. 
¾ Avoidance of drug degradation. 
¾ Prolonged effect. 
¾ High drug flux through the absorbing tissue. 
¾ Reduction in fluctuation of steady state plasma level.  
o An ideal dosage form is one, which attains the desired therapeutic 
concentration of drug in plasma and maintains constant for entire duration 
of treatment. This is possible through administration of a conventional 
dosage form in a particular dose and at particular frequency. In most cases, 
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the dosing intervals much shorter than the half life of the drug resulting in 
a number of limitations associated with such a conventional dosage form 
are as follows: 
¾ Poor patient compliance; increased chances of missing the dose of a drug with 
short half-life for which frequent administration is necessary. 
¾ A typical peak plasma concentration time profile is obtained which makes 
attainment of steady state condition difficult. 
¾ The unavoidable fluctuation in the drug concentration may lead to under 
medication or over medication as the steady state concentration values fall or rise 
beyond in the therapeutic range. 
¾ The fluctuating drug levels may lead to precipitation of adverse effects especially 
of a drug with small therapeutic index whenever overmedication occurs 
Advantages of mucoadhesives                                    (S.Punitha and S.Ganga., 2007) 
¾ A prolonged residence time at the site of drug action or absorption. 
¾ A localization of drug action of the delivery system at a given target site. 
¾ An increase in the drug concentration gradient due to the intense contact of 
particles with the mucosal.  
¾ A direct contact with intestinal cells that is the first step before particle 
absorption.  
¾ Ease of administration. 
¾ Termination of therapy is easy.{except gastrointestinal} 
¾ Permits localization of drug to the oral cavity for a prolonged period of time. 
¾ Can be administered to unconscious patients. Except gastrointestinal} 
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¾ Offers an excellent route, for the systemic delivery of drugs with high first pass 
metabolism, there by offering a greater bioavailability 
¾ A significant reduction in dose can be achieved there by reducing dose related 
side effects. 
¾ Drugs which are unstable in the acidic environment are destroyed by enzymatic or 
alkaline environment of intestine can be administered by this route. Eg. Buccal 
sublingual, vaginal. 
¾ Drugs which show poor bioavailability via the oral route can be administered 
conveniently. It offers a passive system of drug absorption and does not require 
any activation. 
¾ The presence of saliva ensures relatively large amount of water for drug 
dissolution unlike in case of rectal and transdermal routes. 
¾ Systemic absorption is rapid.  
¾ This route provides an alternative for the administration of various hormones, 
narcotic analgesic, steroids, enzymes, cardiovascular agents etc.\ 
¾ The buccal mucosa is highly perfused with blood vessels and offers a greater 
permeability than the skin.  
¾ Less dosing frequency. 
¾ Shorter treatment period. 
¾ Increased safety margin of high potency drugs due to better control of plasma 
levels. 
¾ Maximum utilization of drug enabling reduction in total amount of drug 
administered. 
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¾ Improved patient convenience and compliance due to less frequent drug 
administration. 
¾ Reduction in fluctuation in steady state levels and therefore better control of 
disease condition and reduced intensity of local or systemic side effects.  
¾ Despite the several advantages associated with oral controlled drug delivery 
systems, there are so many disadvantages, which are as follows: 
¾ Basic assumption is drug should absorbed throughout GI tract 
¾ Limited gastric residence time which ranges from few minutes to 12 hours which 
lead to unpredictable bioavailability and time to achieve maximum plasma level.  
1.6. Limitations of mucoadhesion  
¾ Drug administration via the buccal mucosa has certain limitations 
¾ Drugs, which irritate the oral mucosa, have a bitter or unpleasant taste, odour, 
cannot be administered by this route. 
¾ Drugs, which are unstable at buccal pH cannot be administered by this route. 
¾ Only drugs with small dose requirements can be administered. 
¾ Drugs may swallow with saliva and loses the advantages of buccal route. 
¾ Only those drugs, which are absorbed by passive diffusion, can be administered 
by this rout. 
¾ Eating and drinking may become restricted. 
¾  Swallowing of the formulation by the patient may be possible. 
¾ Over hydration may lead to the formation of slippery surface and structural 
integrity of theformulation may get disrupted by the swelling and hydration of the 
bioadhesive polymers. 
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1.7. Stages of mucoadhesion                                                        (S. P. Vyas.,2002) 
1. Contact Stage  
2. Consolidation Stage. 
¾ Contact Stage: The first stage is characterized by the contact between the 
mucoadhesive and the mucous membrane, with spreading and swelling of the 
formulation, initiating its deep contact with the mucus layer.  
¾ Consolidation Stage: In the consolidation step (Figure 1), the mucoadhesive 
materials are activated by the presence of moisture. Moisture plasticizes the 
system, allowing the mucoadhesive molecules to break free and to link up by 
weak Vander Waals and hydrogen bonds.  
 
 
 
 
 
 
               
 
 
 
 
 
Figure 1.3: The two steps of the mucoadhesion process 
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1.8. Theories of mucoadhesion                                                      (Jain N.K., et al., 2004) 
1. Electronic Theory  
The adhesive polymer and mucus membrane strategically have different 
electronic characteristics. When the two surfaces contact each other, a double layer of 
electrical charge is formed at the interface, and then adhesion developed between the 
double layers due to electrical charge.  
2. Adsorption Theory 
 The adsorption theory of bioadhesion proposes two bond theories:  
(i) Primary chemical bonds permanent and therefore undesirable in bioadhesion 
(ii) Secondary chemical bonds are found to be van-der Waals, hydrogen, hydrophobic 
and electrostatic forces.  
3. Wetting Theory 
 The wetting theory emphasizes mainly on the intimate contact between the 
adhesive and mucus. Thus, a wetting surface will be controlled by structural similarity, 
degree of cross linking of the adhesive polymer, or use of a surfactant. 
4. Diffusion Theory  
 A semi permanent adhesive bond is formed because of the chains of adhesive and 
the substrate interpenetrates one another to a sufficient depth and it is considered as the 
essence of this theory. The diffusion coefficient of both interacting polymers and the 
diffusion co-efficient are the factors responsible for the penetration rate. In addition 
mobility, flexibility of the bioadhesive polymer, mucus glycoprotein, and the expanded 
nature of both network are other important parameters considered. 
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1.9. Mechanism of mucoadhesion                                        (J.H.Bhatt and Aidoo., 2009) 
The concept of mucoadhesion is one that has the potential to improve the highly 
variable residence times experienced by drugs and dosage forms at various sites in the 
gastrointestinal tract, and consequently, to reduce variability and improve efficacy. 
Intimate contact with the mucosa should enhance absorption. 
The mechanisms responsible in the formation of bioadhesive bonds are not fully known, 
however most research has described bioadhesive bond formation as a three step process. 
 
 
 
 
 
 
 
 
Figure 1.4:  Interaction of mucoadhesive drug delivery system with mucous layer 
STEP 1: Wetting and swelling of polymer 
STEP 2: Interpenetration between the polymer chains and the mucosal membrane. 
STEP 3: Formation of Chemical bonds between the entangled chains. 
¾ Step 1 
The wetting and swelling step occurs when the polymer spreads over the surface 
of the biological substrate or mucosal membrane in order to develop an intimate contact 
with the substrate. 
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This can be readily achieved for example by placing a bioadhesive formulation 
such as a tablet or paste within the oral cavity or vagina. Bioadhesives are able to adhere 
to or bond with biological tissues by the help of the surface tension and forces that exist 
at the site of adsorption or contact. Swelling of polymers occurs because the components 
within the polymers have an affinity for water. 
  
 
 
 
 
 
 
                                 
Figure 1.5: Wetting and Swelling of Polymer 
 
¾ Step 2  
The surface of mucosal membranes is composed of high molecular weight 
polymers known as glycoproteins. In this step interdiffusion and interpenetration take 
place between the chains of mucoadhesive polymers and the mucous gel network creating 
a great area of contact. The strength of these bonds depends on the degree of penetration 
between the two polymer groups. In order to form strong adhesive bonds, one polymer 
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group must be soluble in the other and both polymer types must be of similar chemical 
structure. 
                  Interdiffusion and interpenetration 
 
Figure 1.6: Interdiffusion and Interpenetration of Polymer and Mucus 
¾ Step 3 
In this step entanglement and formation of weak chemical bonds as well as 
secondary bonds between the polymer chains mucin molecule The types of bonding 
formed between the chains include primary bonds such as covalent bonds and weaker 
secondary interactions such as van-der Waals Interactions and hydrogen bonds. Both 
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primary and secondary bonds are exploited in the manufacture of bioadhesive 
formulations in which strong adhesions between polymers are formed. 
 
            
Figure.1.7: Entanglement of Polymer and Mucus by Chemical bonds 
1) Ionic bonds—where two oppositely charged ions attract each other via electrostatic 
interactions to form a strong bond (e.g. in a salt crystal). 
2) Covalent bonds—where electrons are shared, in pairs, between the bonded atoms in 
order to fill the orbital in both. These are also strong bonds. 
3) Hydrogen bonds—here a hydrogen atom, when covalently bonded to electronegative 
atoms such as oxygen, fluorine or nitrogen, carries a slight positively charge and is 
therefore is attracted to other electronegative atoms. The hydrogen can therefore be 
thought of as being shared, and the bond formed is generally weaker than ionic or 
covalent bonds. 
4) Van-der-Waals bonds—these are some of the weakest forms of interaction that arise 
from dipole– dipole and dipole-induced dipole attractions in polar molecules, and 
dispersion forces with non-polar substances. 
5) Hydrophobic bonds—more accurately described as the hydrophobic effect, these are 
indirect bonds (such groups only appear to be attracted to each other) that occur when 
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Maximum loading can be achieved by incorporating the drug at the time of 
preparation but it may get affected by many other process variables such as method of 
preparation, presence of additives heat of polymerization, agitation intensity etc.  drug in 
loading in pre-formed microspheres is relatively less but the major advantage of the 
loading method is that there is no effect of process variables, loading is carried out in 
preformed microsphere by incubating them with high concentration of drug in a suitable 
solvent.  The drug in these microspheres is loaded by penetration or diffusion through the 
pores. 
 
Figure 1.9: Different methods employed for microspheres 
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1.11. Methodology                  (Belgamwar  ., 2010) 
The selected methods of Mucoadhesive microspheres was prepared by, 
Ionic Orifice Gelation Technique 
In this technique cross linking of sodium alginate is done with calcium chloride 
solution to release the drug in a controlled manner.  Chemically alginates are anionic 
block co-polymer consisting monomers of d – mannoic acid joined together by 1-4 
glycosidic linkages.  Bivalent alkaline earth metals like calcium undergoes ionic 
interaction with COOH moiety of sodium alginate and results in cross linking of sodium 
alginate. Microspheres were prepared by using the technique in which sodium alginate in 
different ratios as mentioned then added mucoadhesive polymers was slowly added to the 
above solution with continuous stirring to form homogenous solution. 
After the aqueous sodium alginate solution by sonicating the mixture for 20 
minutes the drug substance Quetiapine fumarate was then added to the above solution to 
form a clear solution (polymer – alginate mixture).  The drug polymer mixture is 
dispersion was poured in 15% calcium chloride solution using 22# needle by stirring at 
50rpm the microspheres thus formed are allowed 30 min for curing in calcium chloride 
solution then were decanted and washed with distilled water and air dried over night at 
room temperature. 
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Coacervation-Phase Separation 
The general outline of the processes consists of three steps carried out under 
continuous agitation. 
1. Formation of three immiscible chemical phases 
 A liquid manufacturing phase, a core material and a coating material. To form the 
three phases, the core material dispersed in a solution of the coating polymer, the solvent 
for the polymer being the liquid manufacturing vehicle phase.  
2. Deposition of the coating 
 It is mainly of depositing the liquid polymer coating upon the core material. This 
is obtained by controlled, physical mixing of the material in the manufacturing vehicle. 
Deposition of the liquid polymer coating around the core material occurs only if the 
polymer is adsorbed at the interface between the core material and the liquid vehicle 
phase. The continued deposition of the coating material is improved by a reduction in the 
total free interfacial energy of the system. 
3. Rigidization of the coating 
It involves mainly in rigidizing the coating, usually by thermal, cross-linking, or 
desolvation techniques, to form a self-sustaining microspheres. 
Pan coating 
 The pan coating process, mainly used in the pharmaceutical industry, is among 
the oldest industrial procedures for forming small, coated particles or tablets. The 
particles are mainly tumbled in a pan or other device while the coating material is applied 
steadily and slowly. The particles has been tumbled in pan, while the coating material is 
applied slowly with respect to microspheres, solid particles are greater.  
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Figure 1.11: Pan coating and its process 
Spray–drying 
 Spray drying is an important microspheres technique in this an active material is 
dissolved or suspended in a melt or polymer solution and becomes trapped in the dried 
particle. The main advantages of this ability to handle labile materials because of the 
short contact time in the dryer, in addition, the operation is economical. In modern spray 
dryers, the solutions are to be sprayed can be as high as 300mPa.s. Spray drying and 
spray congealing processes are similar in that both involve dispersing the core material in 
a liquid coating substance and spraying the core - coating mixture into some 
environmental condition, whereby relatively rapid solidification (and formation) of the 
coating is affected. The principal difference between the two methods is the coating 
solidification is obtained. 
 Coating solidification in the case of spray drying is effected by rapid evaporation 
of a solvent, by thermally congealing a molten coating material or by solidifying a 
dissolved coating by introducing the coating - core material mixture into a non-solvent. 
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Removal of the non-solvent or solvent from the coated product is then accomplished by 
sorption, extraction, or evaporation techniques.  
 
 
 
 
 
 
 
 
               Figure 1.12: Spray drying technique and its process 
 
Chemical process 
Solvent Evaporation 
 The liquid manufacturing vehicle is the mainly used for the formulation. The 
coating for the microspheres will be dissolved in a volatile solvent, which has to be 
immiscible with the liquid manufacturing vehicle phase. A core material will be either 
dissolved or dispersed in the coating polymer solution. On agitation, the core coating 
material mixture will be dispersed in the liquid manufacturing vehicle phase to obtain the 
microspheres of appropriate size. The mixture will be then heated (if necessary) to 
evaporate the solvent in the polymer. In the case in which the core material is dispersed 
in the polymer solution, polymer shrinks around the core. 
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 In the case in which core material is dissolved in the coating polymer solution, a 
matrix - type microsphere is formed. Once all the solvent evaporated, the liquid vehicle 
temperature is reduced to ambient temperature (if required) with continued agitation. At 
this stage, the microspheres can also be used in suspension form, coated on to substrates 
or isolated as powders. 
 
 
Figure 1.13: Solvent evaporation process 
 The solvent evaporation technique is used to produce microspheres which are 
applicable to a wide variety of liquid and solid core materials. The core materials may be 
either water - soluble or water - insoluble materials. e.g. “Evaluation of Sucrose Esters as 
Alternative Surfactants in Microspheres of Proteins by the Solvent Evaporation Method”. 
Centrifugal extrusion 
 Liquids are been encapsulated using a rotating extrusion head containing 
concentric nozzles. In this particular process, a core liquid is surrounded by a sheath of 
wall solution or melt. As the jet moves through the air it will break, owing to Rayleigh 
instability, core droplets are formed, each coated with the wall solution. From the 
droplets formed, a molten wall will be hardened or a solvent may be evaporated from the 
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wall solution. This process is excellent for forming making particles 400–2,000 μm (16–
79 mils) in diameter.  
Vibrational Nozzle 
 Micro granulation (matrix-encapsulation) can be done by using a laminar flow 
through a nozzle and an additional vibration of the nozzle. The vibration has to be done 
in resonance and Rayleigh instability leads to form uniform droplets. The liquid should 
be with limited viscosities (0-10,000 mPa·s have been shown to work), e.g. solutions, 
emulsions, suspensions, melts etc. The solidification can be done with an internal 
gelation (e.g. sol-gel processing, melt) or an external (additional binder system, e.g. in a 
slurry). The process works for generating droplets between 100–5,000 µm (3.9–200 
mils), for preparing smaller and larger droplets are known.  
Interfacial polymerization 
 In Interfacial polymerization, Polycondensation of the two reactants occur in 
between. The basis of this method termed as the classical Schotten-Baumann reaction 
between compound an acid chloride containing an active hydrogen atom, such as an 
amine or alcohol, polyesters, polyurea, polyurethane.  
Matrix polymerization 
 In this method, the particle is formed by evaporation of the solvent from the 
matrix material. However, the solidification of the matrix also can be caused by a 
chemical change in a number of processes; a core material is dissolved in a polymeric 
matrix during formation of the particles. A simple example of this kind is actually Spray 
drying method, in which the particle is formed by evaporation of the solvent from the 
matrix material. However the chemical change can also cause solidification of materials. 
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1.13. Release kinetics patterns of microspheres 
  Although, the aim of the microsphere is to protect the core by surrounding wall. 
The wall may get ruptured at the time of usage. microsphere contents may get ruptured 
by melting the wall, dissolving it under particular conditions , as in the case of  an enteric 
coating , in other system it get ruptured by solvent action , enzyme action.  
Microsphere can be used to slow the release of a drug into the body. This may 
help for the controlled release dose to substitute for several doses of non-encapsulated 
drug and also may decrease toxic side effects for some drugs by preventing high initial 
concentrations in the blood.  
1.14. Applications of microspheres                                                        (N. K. Jain 2009) 
1. Microspheres in vaccine delivery. 
2. Targeting using microparticulate carriers 
a. Targeting may be provided by: 
b. By controlling the size of the microspheres 
c. By conjugation with antibodies 
d. By incorporation of magnet particle 
3. Monoclonal antibodies mediated microspheres targeting 
4. Chemoembolisation 
5. Imaging 
6. Topical porous microspheres 
7. Surface modified microspheres 
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2. AIM AND OBJECTIVE 
Atypical antipsychotic Quetiapine was approved by the US food and drug 
administration (FDA) used for the treatment of schizophrenia is a severe illness with 
substantial effects on individual and social functioning, Quetiapine and its active 
metabolite N-desalkyl-Quetiapine have affinities to dopaminergic D1-and D2receptors, 
5-HT2 receptors. It is used orally for the treatment of schizophrenia and has a low 
bioavailability of 9%, because of its poor absorption in lower gastro intestinal tract. It 
undergoes little or no hepatic metabolism and its elimination half life is 6 hrs.  
¾ Quetiapine (seroquel) is available as tablets for oral administration, containing 50 
mg, 100 mg, 200 mg, 300 mg, or 400mg of Quetiapine.  
¾ The once daily dosing of Quetiapine reaches similar overall plasma 
concentrations to the twice daily dosing of immediate release. 
¾ Overview the clinical efficacy of 20 trials have been completed to determine 
Quetiapine in total 3,231 patients have been recruited; 1,677 of these patients 
were diagnosed with schizophrenia, 951 patients took part in short term trials over 
six weeks . 
¾ Switching from Quetiapine immediate release or other antipsychotics to 
Quetiapine microspheres was feasible in a short time and maintained effective 
treatment. 
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Sustained release or controlled release of formulation can be attempted as: 
9 Microsphere’s will provide the sustained release and to reduce the dose 
 dependent side effects as well as to improve patient compliance.  
9 Sustained release and controlled release tablets by using Hydrophilic 
 Matrices to retard and control the rate of drug release.  
9 Liposome drug delivery is to reduce hepatic toxicity enhanced cellular  uptake 
 and alters pharmacokinetics.                          
9 Microspheres for the controlled release of various drugs.   
Objectives:  
The development of efficient orally delivered mucoadhesive drug  delivery 
system includes advantages like: 
 Maximized absorption rate is mainly due to intimate contact of drug with  the 
mucus membrane to improve and enhance bioavailability of drugs.  
 Drug protection is improved by polymer encapsulation and longer gut transit time 
is obtained, resulting in extended periods for absorption. 
 Multiple dosing is avoided and thereby counteracts the side effects.  
 The main objective is mainly to develop alginate mucoadhesive microspheres of 
Quetiapine by orifice-ionic gelation process using mucoadhesive polymers release 
of the drug for extended period of time.   
 Formulate and evaluate the microspheres of Quetiapine. 
 To study the effect of different polymers and different ratios of polymers 
employed. 
 Performing the stability studies as per ICH guidelines. 
  
PLAN OF WORK 
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3. PLAN OF WORK 
 
 LITERATURE  REVIEW 
 SELECTION OF DRUG, POLYMER AND EXCIPIENTS 
 PROCUREMENT OF DRUG, POLYMER AND EXCIPIENTS 
 EXPERIMENTAL WORK 
A) PREFORMULATION STUDY 
 Identification of drug 
 By FTIR spectroscopy 
 By melting point 
 Physicochemical parameters 
 Organoleptic properties  
 Solubility profile 
 Analytical methods 
 Determination  of λmax 
 Development  of standard curve of Quetiapine fumarate  
 Determination of percentage purity of drug 
   Determination of compatibility for drug with polymer 
 By FTIR spectroscopy 
 By DSC thermal analysis 
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B) EVALUATION OF  MUCOADHESIVE MICROSPHERES 
# Percentage yield 
# Particle Size analysis 
# Drug content estimation and Encapsulation efficiency 
# Percentage moisture content 
# Scanning electron microscopy 
# In -vitro wash - off test for mucoadhesion 
# In -vitro drug release studies 
 
C) KINETIC STUDIES 
D) STABILITY STUDIES 
 RESULTS AND DISCUSSION 
 SUMMARY  AND CONCLUSION 
 FUTURE PROSPECTS 
 BIBLIOGRAPHY 
  
LITERATURE 
REVIEW 
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4.  LITERATURE REVIEW 
 
Literature review indicating advancement in Microsphere drug delivery system is 
given by: 
  Senthil A., et al., (2011) were prepared by glipizide microspheres containing 
chitosan simple emulsification phase separation technique using glutaraldehyde as a 
cross-linking agent. Microspheres were discrete, spherical, and free flowing. The 
microspheres exhibited good mucoadhesive property in the in vitro wash-off test and also 
showed high percentage drug entrapment efficiency. A 32 full factorial design was 
employed to study the effect of independent variables, polymer-to-drug ratio (X1), and 
stirring speed (X2) on dependent variables percentage mucoadhesion, t80, drug 
entrapment efficiency, and swelling index. Percentage mucoadhesion after 1 hour was 
78%. The drug release was also sustained for more than 12 hours.   
Ofokansi KC., et al., (2007) had formulated ceftriaxone sodium-loaded 
mucoadhesive microspheres by the emulsification cross-linking method using arachis oil 
as the continuous phase. The release profile of ceftriaxone sodium from the microspheres 
was evaluated in both simulated gastric fluid (SGF) without pepsin (pH 1.2) and 
simulated intestinal fluid (SIF) without pancreatin (pH 7.4). Release of microspheres by 
diffusion following non-Fickian transport mechanism and was higher and more rapid in 
SIF than in SGF. The results obtained from this study may indicate that ceftriaxone 
sodium could be successfully delivered rectally when embedded in microspheres 
formulated with either type a gelatin alone or its admixtures with porcine mucin. 
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 Dhamane Aligave H., et al., (2011) had formulated and evaluated the potential 
use of mucoadhesive Carbopol 934P microspheres for gastroretentive delivery of 
Cefuroxime Axetil. Microspheres were prepared by spray drying technique using 32 full 
factorial designs. The formulated Microspheres were characterised for Mucoadhesion 
time, Encapsulation Efficiency, Particle size analysis, DSC, XRD, IR and In-vitro drug 
release. The result of mucoadhesion study shows better retention (320±15 min) of 
formulation in upper part of GIT. The release of the drug was prolonged up to 10hrs 
(96.46±0.76).  
        Shee Dutta Maurya., et al., (2010) had formulated and systemically evaluated of 
mucoadhesive propranolol hydrochloride microspheres for its potential use in the 
treatment of hypertension, myocardial infraction and cardiac arrhythmias. This 
containing carbopol-934P as mucoadhesive polymer and ethyl cellulose as carrier 
polymer, were prepared by an emulsion-solvent evaporation technique of time. A 32 full 
factorial design was employed to study the effect of independent variables, drug-to-
polymer-to-polymer ratio the best batch exhibited a high drug entrapment efficiency of 
54 %; 82% mucoadhesion after 1 h and particle size of 110 µm. A sustained pattern of 
drug release was obtained for more than 12 h.  
Vijay Kumar Tilak., et al., (2010) were prepared repaglinide mucoadhesive 
microspheres by the emulsion solvent evaporation technique consisting of chitosan 
mucoadhesive, an oral hypoglycemic agent and Eudragit RS-100 as polymer. The 
microspheres were also evaluated for their microencapsulation efficiency, in vitro wash-
off mucoadhesion test, in vitro drug release and in vivo study. All the formulations were 
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followed by Matrix-Peppas model. The drug release was also found to be slow and 
extended for 24 h. 
 Madhavi Boddupalli B., et al., (2010) was to formulated and evaluated 
mucoadhesive microsphers of Venlafaxine Hydrochloride by using carbopol and HPMC 
K4M as mucoadhesive polymers. There was sustained release up to 12 hours and almost 
70% of mucoadhesion was observed after 12 hours. The results were encouraging and 
further studies are required for in-vivo efficiency. 
  Okore VC., et al., (2010) were successfully prepared by emulsification-internal 
gelation technique with a maximum incorporation efficiency of 93.29 ± 0.26%. The in 
vitro wash-off test indicated that the microspheres had good mucoadhesive properties. 
The wash-off was faster at simulated intestinal fluid (phosphate buffer, pH 7.4). The in 
vitro drug release mechanism was non-fickian type controlled by swelling and relaxation 
of polymer. There was no significant change in drug content and cumulative drug release 
of drug-loaded microspheres stored at different storage condition after 8 weeks of study. 
 Rajeshwarkant R., et al., (2010) had characterized of mucoadhesive microspheres 
with Famotidine as model drug for prolongation of gastric residence time Using 
mucoadhesive polymers sodium CMC and sodium alginate. In vitro drug release studies 
were performed and drug release evaluated. The prepared microspheres exhibited 
prolonged drug release (8h). The In vitro studies demonstrated diffusion-controlled drug 
release from the microspheres. 
Shiv Shankar Hardenia., et al., (2011) were prepared and evaluated 
ethylcellulose microspheres containing ciprofloxacin for in-vitro performance of 
ciprofloxacin. Ciprofloxacin microspheres containing ethylcellulose were prepared by 
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emulsion solvent diffusion evaporation method. The best cumulative release was 
achieved after 24 hrs i.e. 91.6%. The Mucoadhesive property of the ethylcellulose 
microspheres was evaluated by in-vitro wash off test. The microspheres exhibited 75% 
mucoadhesion and showed good drug entrapment efficiency. By, above results it was 
concluded that ethylcellulose microspheres showed reproducible results, with good 
Mucoadhesive properties and good surface morphology. 
Nagda Chirag., et al., (2009) were designed, characterized and evaluated 
bioadhesive microspheres of ACE employing polycarbophil as bioadhesive polymer. 
Bioadhesive microspheres of ACE were prepared by double emulsion solvent 
evaporation method. The in-vitro release studies were performed using pH 6.8 phosphate 
buffer. The drug loaded microspheres in a ratio of 1:5 showed 38 % of drug entrapment, 
percentage mucoadhesion was 79 % and 89 % release in 10 h. The in vitro release 
profiles from microspheres of different polymer-drug ratios followed Higuchi model.  
Ram Chand Dhakar., et al., (2010) were prepared and evaluated by 
emulsification solvent evaporation method using Sodium carboxy methyl cellulose 
(SCMC), Carbopol 934P (CP), and Hydroxyl propyl methyl cellulose K4M (HPMC) as a 
mucoadhesive polymers. Microspheres prepared were found discrete, spherical and free 
flowing. Among all the formulation, formulation F1 containing SCMC and F2 containing 
CP showed the best reproducible results and mucoadhesive profile with good surface 
morphology. 
Nalanda Rangari T., et al., (2010) was to formulated and systematically 
evaluated in vitro performance of mucoadhesive microsphere of Pioglitazone HCL. 
Pioglitazone HCL mucoadhesive microsphere were prepared from Orifice Ionic Gelation 
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Method using variouspolymers viz, Sodium Alginate, Carbopol 934 P, Carbopol 971 P 
NF, Carbopol 974 P NF,HPMC K 100 M and Polycarbophil in different proportion. The 
best batch exhibited a high drug entrapment efficiency of 65% and a swelling index of 
1.21 percentage mucoadhesion after 1 hour was 78%. The drug release was also sustained 
for more than 12 hours. 
Mahendra Singh., et al., (2011) had prepared by emulsion cross linking method 
using Glutaradehyde as a cross linking agent. Gelatin A and Chitosan were used as 
polymer and co polymer respectively. All the prepared microspheres were evaluated for 
physical characteristics, such as particle size, incorporation efficiency, swelling index, in 
vitro bioadhesion using rat jejunum and in vitro drug release in pH 6.6 phosphate buffer. 
The data indicates the verapamil hydrochloride release followed Higuchi’s matrix and 
Peppas model. Stability studies showed stability of formulation at all the conditions to 
which the formulations were subjected. 
Venkateswaramurthy N., et al., (2011) was to designed and characterized 
mucoadhesive microspheres containing Clarithromycin as an anti‐H. pylori agent to 
deliver the drug specifically to mucus layer where H.pylori resides and evaluate the 
effectiveness of the mucoadhesive microspheres for H. pylori eradication therapy. 
Microspheres were prepared by using Eudragit RL100 as matrix and Carbopol 974P as a 
mucoadhesive polymer. The microspheres were prepared by emulsion solvent 
evaporation technique. The prepared microspheres were evaluated with respect to the 
particle size, production yield, encapsulation efficiency, shape and surface properties, 
mucoadhesive property, in vitro drug release and suitability for anti Helicobactorpylori 
effect. 
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 Jhbhatt., et al., (2009) were prepared Metronidazole Microsphere employing 
sodium alginate in combination with four mucoadhesive polymers – sodium CMC, 
Methylcellulose, Carbopol and HPMC-K4M as coat materials with different polymers 
ratios. The microspheres were found to discrete, spherical, free flowing, and of the 
monolithic matrix type. The mucoadhesive microspheres were evaluated by in vitro and 
in vivo methods using Gamma Scintigraphy for controlled release. 
Venkateswaramurthy S., et al., (2010) had formulated and systematically 
evaluated in vitro performances of Furazolidone mucoadhesive microspheres were 
prepared by simple emulsification phase separation technique using Eudragit RS100 as 
matrix and Carbopol 974P and Hydroxy propyl methyl cellulose K4M as mucoadhesive 
polymer. The prepared microspheres were evaluated with respect to the particle size, 
encapsulation efficiency, shape and surface properties, mucoadhesive property, in vitro 
drug release and suitability for anti Helicobacter pylori effect. The best batch exhibited a 
high drug entrapment efficiency of 82.12 % and percentage mucoadhesion after 1 h was 
93.35 %. The drug release was also sustained up to 12 h.  
 Nishanth Kumar N., et al., (2011) was formulated and evaluated gliclazide 
mucoadhesive microsphere using hydroxypropylmethylcellulose K4M and 
carboxymethylcellulose as polymers were prepared by simple emulsification phase 
separation technique using glutaraldehyde as across-linking agent. Twenty preliminary 
trial batches, F1 to F20 batches of microspheres were prepared by using different volume 
of cross-linking agent, cross-linking time and 3:1 polymer-to-drug ratio. Among the two 
polymers, the best batch was hydroxypropylmethylcellulose K4M exhibited a high drug 
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entrapment efficiency of 69% and a swelling index1.16 % mucoadhesive after 1hour was 
70% and the drug release was also sustained for more than 10 h.  
 Saravanakumar K., et al., (2011) were formulated and developed of naproxen 
sodium microsphere two investigated factors (independent variables) were the stabilizer 
agent concentration in the aqueous phase (%w/v PVA) and the polymer concentration in 
the organic phase (%w/v HPMC K15M).The results showed that encapsulation efficiency 
was significantly affected by the two investigated factors, with PVA concentration having 
a highly negative effect, probably due to naproxen sodium’s solubility enhancement in 
the aqueous phase in the presence of higher amounts of stabilizer. These results 
demonstrate hat it is possible to control the quantity of drug loaded in the microspheres.  
  Dasai Sapna., et al., (2010) had formulated and systematically evaluated the 
performances of mucoadhesive microspheres of midazolam containing carbopol 934P 
were prepared by emulsion cross linking technique using glutaraldehyde as a cross-
linking agent. Results of preliminary trials indicate that volume of cross-linking agent, 
time for cross-linking, polymerto- drug ratio and speed of rotation affected characteristics 
of microspheres. The best batch exhibited a high drug entrapment efficiency of 93% and 
a swelling index of 1.11% and in vitro bioadhesion was 89%. The drug release was also 
sustained for 12 h. 
 Malay Das K., et al., (2008) were developed of diltiazem-loaded mucoadhesive 
microspheres successfully prepared by emulsification-internal gelation technique using 
different polymers. The scanning electron microscopic study indicated that the 
microspheres were spherical in shape. The in vitro wash-off test indicated that the 
microspheres had good mucoadhesive properties. The wash-off was faster at simulated 
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intestinal fluid (phosphate buffer, pH 7.4) than that at simulated gastric fluid (0.1 M HCl, 
pH 1.2). The in vitro drug release mechanism was non-fickian type controlled by 
swelling and relaxation of polymer. 
Veena Belgamwar., et al., (2009) was to prepared and evaluated mucoadhesive 
multiparticulate system for oral drug delivery using ionic gelation technique. 
Microspheres composed of various mucoadhesive polymers including HPMC of various 
grades like K4M, K15M, K100M, E50LV, Carbopol of grades 971P, 974P and 
polycarbophil were prepared. In this technique cross linking of sodium alginate with 
calcium chloride was done which retarded the release of drug from the mucoadhesive 
polymer. Metoprolol release from the multiparticulate system was regulated and extended 
until 12 hours and exhibited a non fickian drug release kinetics approaching to zero order, 
as evident from the release rate exponent values which varied between 0.57 to 0.73. The 
stability studies performed on the optimized batches at 40°C / 75% RH for 90 days.  
Hamouda AO., et al., (2010) were developed controlled release amoxicillin 
trihydrate (MOX) and Chitosan, a cationic polymer was selected as and sodium 
carboxymethyl cellulose (Na CMC), an anionic polymer was selected for mucoadhesion 
and sustained release respectively. The preparation of microspheres was carried out using 
ionic gelation method. Release profile followed zero order kinetic with around 20 % 
constant drug release per hour up to 5 h. Therefore, it is safely concluded that 
mucoadhesive controlled release microspheres of amoxicillin were successfully 
developed and can be used for optimum delivery of MOX either for local gastric 
infections or for systemic drug delivery. 
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Yadav S., et al., (2011) had to formulate and evaluated sustained release 
mucoadhesive microspheres of Acyclovir loader Sodiumcarboxymethylcellulose and 
hydrxypropylmethylcellulose were used as mucoadhesive polymers. The microspheres 
were prepared using solvent evaporation technique. The results of mucoadhesion study 
showed better retention of Sodium CMC microspheres (8.0±0.8 h) in duodenal and 
jejunum regions of intestine. Overall, the result indicated prolonged delivery with 
significant improvement in oral bioavailability of acyclovir from mucoadhesive 
microspheres due to enhanced retention in the upper GI tract. 
Literature review indicating work carried out on selected drug, quetiapine fumarate 
is given below: 
Deepak Sahu., et al., (2010) was developed sustained release matrix tablets of 
quetiapine fumarate using different polymers viz. Hydroxy propyl methyl cellulose 
(HPMC) and PVP K30. After evaluation of physical properties of tablet, the in vitro 
release study was performed in 0.1 N HCl, pH 1.2 for 2 h and in phosphate buffer pH 6.8 
up to 12 h. Dissolution data was analyzed by Higuchi expression. Among all the 
formulations, formulation QFSRT/08 which contains 60% HPMC K15M and 06% of 
PVP K30 release the drug which follow Higuchi kinetics via, swelling, diffusion and 
erosion and the release profile of formulation QFSRT/08 was comparable with the 
prepared batch products. Stability studies (40±2ºC/75±5%RH) for 6 months indicated 
that quetiapine fumarate was stable in the matrix tablets.  
Jaydeep Patel., et al., (2010) were prepared sustained release microspheres of the 
anti-psychotic drug, quetiapine fumarate, using ethyl cellulose as the polymer and 
utilizing emulsion solvent evaporation and extraction technique. A 32 factorial factorial 
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design was applied to investigate the influence of drug: polymer ratio and average 
particle size on release characteristics. The optimized batch showed no signs of 
interaction with sustaining the drug release up to 12 h along with identical release 
behavior to that of marketed sustained release tablet.  
Pattanyak Durga., et al., (2011) had prepared and characterized sustained release 
matrix tablets of quetiapine fumarate using different polymers viz., Hydroxy propyl 
methyl cellulose (HPMC) and PVP K30. After evaluation of physical properties of tablet, 
the in vitro release study was performed in 0.1 N HCl, pH 1.2 for 2 h and in phosphate 
buffer pH 6.8 up to   12 h. The effect of polymer concentration and polymer blend 
concentration were studied. Dissolution data was analyzed by Higuchi expression. 
Among all the formulations, formulation QFSRT/08 which contains 60% HPMC 
K15Mand 06% of PVP K30 release the drug which follow Higuchi kinetics via, swelling, 
diffusion anderosion and the release profile of formulation. Stability studies 
(40±2ºC/75±5%RH) for 6 months indicated that quetiapine fumarate was stable in the 
matrix tablets. 
Haresh T Mulani., et al., (2011) was selected as a model drug for our present 
investigation. Quetiapine shows pH dependent solubility, using Eudragit L30 D55, 
Sodium alginate and HPMC was used as retarding and matrix forming agent respectively. 
The prepared granules and tablets were characterized for its pharmaceutical properties, 
drug release studies and release kinetics. The ratio of HPMC and sodium alginate was 
studied and found suitable in ratio of 1:1, 1: 1.5, and 1.5:1 when used with 10 % 
acidifying and granulating agent to achieve not only desired release profile but also for 
better pharmaceutical standards. 
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Kiran Kumar M., et al., (2010) were to overcome this problem by utilizing 
Succinic acid as pH adjuster and to achieve pH-independent release from matrix and 
coated tablets. Eudragit-RSPO was used as matrix former and Eudragit-RSPO & RLPO 
mixture was employed for coating of tablets. Drug release from tablets was studied in pH 
1.2 and 6.8 buffers. Effect of addition of Succinic acid on drug release and drug: Succinic 
acid ratio on drug release was studied. The release of Quetiapine Fumarate from 
Eudragit- RLPO and RSPO coated tablets was found to be constant and more pH-
independent than matrix tablets containing Eudragit RSPO. 
 
Ram Chand Dhakar., et al., (2008) had to formulate and evaluate mucoadhesive 
microspheres of rosiglitazone maleate were prepared by emulsification solvent 
evaporation techniques. Microspheres were found discrete, spherical and free flowing. 
Among all the formulations containing carbopol 934 showed good mucoadhesive 
property.the work has demonstrated that among all the formulations of microspheres, 
particularly formulation F1 are promising candidates for the sustained release in 
gastrointestinal tract. 
 DRUG AND 
EXCIPIENTS 
PROFILE 
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5.1: Drug profile 
(www.rxlist.com/cgi/generic 2/quetiapine) 
Quetiapine is an antipsychotic drug (Merck index, 1998) 
 
 
 
 
Molecular Formula : (C21 H25N3O2S) 2. C4H4O4 
Chemical Name : 2-[2-(4-dibenzo {b,f)[1,4] thiazepin-11-yl-1-iperazinyl) 
ethoxy] Fumarate. 
Molecular Weight  : 883.11dalton 
Melting Point   : 172 - 174°C 
Synonyms  : seriqyek 
Physical State  : white to off – white crystalline powder 
Solubility  : slightly soluble in water and soluble in methanol. 
5. DRUG AND EXCIPIENTS PROFILE 
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Clinical pharmacology 
Pharmacodynamics (or) Mechanism of action           
Seroquel is an antagonist at multiple neurotransmitter receptors in the brain. 
Seroquel is an antagonist at 5HTIA and 5HT2, dopamine D1 and D2 histamine H1 and at 
adrenergic α1 and α2 receptors. 
Seroquel has not appreciable affinity at cholinergic muscarnic and 
benzodiazinereceptgors. Seroquel’s antagonism of histamine H1 receptors may explain 
the somnolence observed with this drug. Seroquel’s antagonism of adrenergic α1 
receptors may explain the orthostatic hypotension. 
Pharmacokinetics:                                                (Goodman and Gilman’s., 2006) 
Parameters                                      values 
Availability of oral                 :          9% 
Urinary excretions                  :         <1% 
Bound in plasma                     :          83% 
Clearance                                :          19mlmin-1. Kg-1 
Volume of distributions          :          10±4liters/kg 
Half life                                   :          1-6 hours 
Peaktime                                  :         1-1.8 hours 
Peak concentrations                 :         278 ng/ml 
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The multiple dose pharmacokinetics of quetiapine is dose proportional within the 
proposed clinical dose range and quetiapine accumulation is predictable upon multiple 
dosing. 
Absorption 
Quetiapinefumarate is rapidly absorbed after oral administration, reacting peak 
plasma concentration in 1.5 hours.  The tablet forumulation is 100% bioavilabile relative 
to solution. 
Distribution 
Quetiapine is widely distributed throughout the body. It is 83% bound to plasma 
proteins at therapeutic concentration. 
Metabolism 
Quetiapine is extensively metabolized by the liver.The major metabolic pathways 
are sulfoxidation to the sulfoxable metabolite and oxidation to the parent acid metabolite. 
Elimination 
Following a single oral dose of 14° C – quetiapine, less than 1% of the 
administrated dose was excreted as unchanges drug. Approximately 73% and 20% was 
recovered in the urine and focus respectively. 
Population subgroups 
Age – oral clearance of quetiapine was reduced by 40% in elderly patients 
compared to young patients. 
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Gender:  there is no gender effect o the pharmacokinetics of quetiapine 
Race: there is no gender effect on the pharmacokinetics 
Smoking – smoking has no effect on the oral clearance of quetiapine 
Indications and usage 
Bipolar mania 
Seroquer is indicated for thetreatment of acutemanic episodes associated with 
bipolar disorder, as either monotherapy or adjuct therapy to lithium (or) 
diralproex. Schizophrenia, Seoquer is indicated for the treatment of schizophrenia 
Dosage and administration 
Bipolar mania 
Seroquer should be intiated in bipolar manic patients with 100mg BID dose on 
first day, followed by an increment dose of 100mg/day uptoan maximum intake 
of 800mg/day. 
Schizophrenia 
Seroquer should be initiated in schizophrenic patients with 250mg BID dose on 
first day, followed by an increment dose of 25 to 50mg/day maximum intake of 
300 to 400mg/day, either in BID to TID. 
Adverse effects 
The most frequent adverse effects with quetiapinehas been somnolence. Other 
adverse effects have included mild asthemia, anxiety, dizziness, myalgia, rhinithis, 
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dyspepsia and rises in plasma triglyceride levels. There have been rare reports of 
priapism (or) peripheral oedema. 
Drug abuse and dependence 
Clinical trials did not reveal any tendency for any drug seeking behavior of the 
drug quetiapinefumarate. 
Drug Interactions: Quetiapine is metabolized in the liver with the help of CYP 3A4 
Isoenzyrnes. Ouetlapine does not inhibit any of the CYP 450 isoenzymes nor does it 
appear to induce the CYP 3A4Isoenzymes, because of these properties it is unlikely to 
affect metabolism of drugs mediated through CYP 450 enzymes. However drugs that 
alter the activity of CYP 3A4isoenzymes have the potential for drug interactions with 
quetiapine. 
Table 5.1: Common drug interaction with Quetiapine 
S.No Interacting Drug Effect of Interaction 
1. Carbamazepine May increase  metabolism level 
2. Erythromycin, Clarithromycin Possible decrease metabolism, increase 
side effects 
3. Fluvoxamine Possible decrease metabolism, increase 
side effects 
4. Ketoconazole, Itraconazole, 
fluconazole, Verapamil, diltiazem 
Possible decrease metabolism, 
increased levels, side effects 
5. Nefazodone Possible decrease metabolism, 
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increased levels, side effects 
6. Phenyotin Increased Quetiapine clearance, 
decreased levels 
7. Thioridazine May Increase Quetiapine clearance 
level. 
8. Diazepam and alcohol Causes  orthostatic hypotention 
9. Alprazolam Causes  orthostatic hypotention 
10. Terazosin Causes  orthostatic hypotention 
 
Overdosage 
Hypotension tachycardia and somnolence were the main clinical events observed 
in quetiapine overdosage.  A symptomatic prolongation of the AT interval was also 
observed on quetiapine overdosage. 
Contraindications: 
Seroquer is contraindicated in individuals with a known hypersensitivity to this 
mediation (or) any of its ingredients. 
Precautions 
In USA it is recommended the patients should have an eye examination to detect 
cataract formation before starting therapy with quetiapine and every 6 months during 
treatment. 
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Patient information 
• Patients should be advised not to breast feed if they are taking seroquel. 
• Patients should be advised to notify their physician if they become pregnant (or) 
intend to become pregnant during therapy.  
• Patients should be advised to avoid consuming alcoholic beverages white taking 
seroquel. 
• Patients should be advised regarding appropriate care in avoiding overheating and 
dehydration. 
Dosage 
Initially 25mg bid, increase 50 to bid, usual dose range 300 – 450mg daily max; 
750mg/dayelderly initially, 25mg daily. 
TRADE NAMES 
SEROQUEL 
• Tablets25mg. 
• Tablets100mg. 
• Tablets 400mg. 
SEROQUEL XR 
 Tablets 50mg, 100mg, 200mg, and 400mg.    
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Disease profile 
 Schizophrenia is a common and serious mental disorder in which majority of 
patients require long - term antipsychotic treatment.Despite the availability of effective 
antipsychotics, functional outcome in schizophrenic patients has not changed 
significantly over the past century. They may be -related to the fact that while first 
generation drugs improves positive symptoms of schizophrenia in the majority of 
patients, they have little impact an negative symptoms or neurocognitive 
functionQuetiapine is a new atypical dibenzothiazepine antipsychotic introduced that is 
expected to fulfil the main goals in treatment of schizophrenia. Above these, it has effect 
on affective symptoms for difficult cases of schizoaffective disorders, depression with 
psychosis and other mixed conditions.Quetiapine is very well tolerated, with no 
requirement for routine anti parkinsonian drugs. It is safe for heart with no requirement 
for routine ECG and blood monitoring. It is the only first line antipsychotic with placebo 
level Extra Pyramidal Side effects as reported by number of studies.  
5.2: POLYMERPROFILE  
5.2.1:SODIUM ALGINATE (Raymond C., et al.,2003) 
¾ Nonproprietary Names 
BP  : Sodium alginate,  
PhEur : Natriialginas,  
USPNF : Sodium alginate 
¾ Synonyms 
  Algin; alginic acid, sodium salt; E401; Kelcosol; Keltone; Protanal; sodium 
 polymannuronate. 
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¾ Chemical Name and CAS Registry Number 
   Sodium alginate [9005-38-3] 
¾ Empirical Formula 
(C
6
H
7
O
6
Na) n 
¾ Molecular Weight 
The block structure and molecular weight of sodium alginate samples has been 
investigated. 
¾  Structural Formula 
 
¾ Functional Category 
  It has stabilizing agent; suspending agent; tablet and capsule disintegrant; tablet 
binder; viscosity-increasing agent. 
¾ Grades  
  Various grades of sodium alginate are available yielding aqueous solutions of 
varying viscosities within a range of 20 to 400 centipoises in 1% solution at 20
º
C. 
¾  Applications in Pharmaceutical Formulation or Technology 
Sodium alginate is used for oral and topical pharmaceutical formulations. 
# In tablet formulations, sodium alginate may be used as both a binder and 
disintegrant,diluents in capsule formulations. Sustained release oral formulations 
are prepared by using, since it can delay the dissolution of a drug from tablets, 
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capsules and aqueous suspensions. In topical formulations, sodium alginate is 
mainly used as a thickening and suspending agent in product such as variety of 
pastes, creams, and gels, and as a stabilizing agent for oil-in-water emulsions  
# Recently, sodium alginate has been used mostly for microencapsulation of 
drugs,contrastwith the more conventional microencapsulation techniques which 
use organic-solvent systems. It has also been used in the formulation of 
nanoparticles. Other NDDS containing sodium alginate include ophthalmic 
solutions that form a gel in situ when administered to the eye. 
¾ Description 
  Sodium alginate occurs naturally as an odorless and tasteless, white to pale   
yellowish-brown colored powder. 
¾ Typical Properties 
  Acidity/alkalinity: pH 7.2 for a 1% w/v aqueous solution 
¾ Solubility 
   Practically insoluble in ethanol (95%), ether, chloroform, and ethanol/water 
mixtures in which the ethanol content is greater than 30%. Also, the pH is less       
than 3. It is slowly soluble in water, forming a viscous colloidal solution. 
¾ Stability and Storage Conditions 
  Sodium alginate is a hygroscopic material, although it is stable if stored at low 
relative humanities and a cool temperature. 
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5.2.2: CARBOMER                                                                  (Raymond C. Rowe, 2003) 
1. Nonproprietary Names 
 BP         :Carbomers 
 PhEur :Carbomera 
 USPNF    :Carbomer 
2. Synonyms 
Acritamer; acrylic acid polymer; Carbopol; Carboxypolymethylene, polyacrylic 
acid; carboxyvinyl polymer; Pemulen; Ultrez 
3. Chemical Name and CAS Registry Number:Carbomer [9003-01-4] 
4. Molecular Weight: 86,000 
5. Structural Formula 
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Carbomer polymers are formed from repeating units of acrylic acid. The 
monomer unit is shown above. The polymer chains are crosslinked with allyl sucrose or 
allylpentaerythritol. 
6. Functional Category 
Bioadhesive; emulsifying agent; release-modifying agent; suspending agent; 
tablet binder; viscosity-increasing agent 
7. Applications in Pharmaceutical Formulation or Technology 
Carbomers are mainly used in liquid or semisolid pharmaceutical formulations as 
suspending or viscosity-increasing agents. Formulations include creams, gels, and 
ointments for use in ophthalmic, rectal, and topical preparations. Carbomer grades, even 
with low residual benzene content, such as carbomer 934P, are no longer included in the 
PhEur 2005. Carbomer having low residuals only of ethyl acetate, such as carbomer 971P 
or 974P, may be used in oral preparations, in suspensions, tablets, or sustained release 
tablet formulations. In tablet formulations, carbomers are used as dry or wet binders and 
as a rate controlling excipient. In wet granulation processes, water or an alcohol–water 
blend is used as the granulating fluid. Anhydrous organic solvents have also been used, 
with the inclusion of a polymeric binder. The tackiness of the wet mass can be reduced 
with the addition of certain cationic species to the granulating fluid or, in the case of 
water, with talc in the formulation.  
 
 
Mucoadhesive Microspheres of Quetiapine Drug and Excipients Profile
 
Adhiparasakthi College of Pharmacy, Melmaruvathur.  Page 63 
 
Table 5.2: Uses of carbopol 974P 
Uses Concentration (%) 
Emulsifying agent 
Gelling agent 
Suspending agent 
Tablet binder 
0.1–0.5 
0.5–2.0 
0.5–1.0 
5.0–10.0 
8. Description 
Carbomers are white-colored, ‘fluffy’, acidic, hygroscopic powders with a slight 
characteristic odour. 
9. Typical Properties 
 Acidity/alkalinity  :     pH = 2.7–3.5 for a 0.5% w/v aqueous dispersion 
pH = 2.5–3.0 for a 1% w/v aqueous dispersion 
 Density (bulk)       :1.76–2.08 g/cm3 
 Density (tapped) :1.4 g/cm3 
 Melting Point      :      Decomposition occurs within 30 minutes at 260°C  
 Moisture Content     
Normal water content is up to 2% w/w. However, carbomers are hygroscopic and 
typicalequilibrium moisture content at 25°C and 50% relative humidity is 8–10% 
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w/w. Themoisture content of a carbomer does not affect its thickening efficiency, but 
an increase inthe moisture content makes the carbomer more difficult to handle 
because it is less readilydispersed. 
 Solubility 
It is soluble in water and after neutralization in ethanol (95%) and 
glycerin.Although they are described as ‘soluble’, carbomers do not dissolve but 
merely swell to aremarkable extent, since they are three-dimensionally crosslinked 
micro gels. Furthermore,the pharmacopeia specifications are unclear, in that 
neutralization with long-chain aliphaticamines or ethoxylated long-chain amines is 
required for swell ability in ethanol, and withwater-soluble amines for swell ability in 
glycerin. 
 Viscosity (dynamic) 
Carbomers disperse in water to form acidic colloidal dispersions of low viscosity 
that, whenneutralized, produce highly viscous gels. Carbomer powders should first be 
dispersed intovigorously stirred water, taking care to avoid the formation of 
indispersible lumps, then neutralized by the addition of a base. The Carbopol ETD 
and Ultrez 10 series of Carbomers was introduced to overcome some of the problems 
of dispersing the powder into aqueous solvents. These carbomer resins wet quickly 
yet hydrate slowly, while possessing a lowerunneutralized dispersion viscosity.  
10. Stability and Storage Conditions 
Carbomers are stable, hygroscopic materials that may be heated at temperatures 
below 104°C for up to 2 hours without affecting their thickening efficiency. 
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However, exposure to excessive temperatures can result in discoloration and reduced 
stability. 
 5.2.3. HYPROMELLOSE (HYDROXYPROPYL METHYLCELLULOSE) 
(Rowe C. 2003) 
1. Nonproprietary Names 
 BP : Hypromellose 
 JP : Hydroxypropylmethylcellulose 
 PhEur :  Hypromellosum 
 USP : Hypromellose 
2. Synonyms  
Benecel MHPC; E464; hydroxypropyl methylcellulose; HPMC; Methocel; 
methylcellulose propylene glycol ether; methyl hydroxypropylcellulose; Metolose; 
Tylopur. 
3. Chemical Name and CAS Registry Number 
             Cellulose hydroxypropyl methyl ether [9004-65-3] 
4. Molecular Weight 
 10,000 – 1,500,000. 
5. Structural Formula 
                            
                             Where R is H, CH3, or CH3CH (OH) CH2 
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6. Functional Category 
            Coating agent; film-former; rate-controlling polymer for sustained release; 
stabilizing agent; suspending agent; tablet binder; viscosity-increasing agent. 
7. Applications in Pharmaceutical Formulation or Technology 
Hypromellose is widely used in oral, ophthalmic and topical pharmaceutical 
formulations. In oral products, hypromellose is primarily used as a tablet binder, in film-
coating, and as matrix for use in extended-release tablet formulations. High-viscosity 
grades may be used to retard the release of drugs from a matrix at levels of 10–80% w/w 
in tablets and capsules. Depending upon the viscosity grade, concentrations of 2-20% 
w/w are used for film-forming solutions to film-coat tablets. Hypromellose at 
concentrations 0.45-1.0% w/w may be added as a thickening agent to vehicles for eye 
drops and artificial tear solutions. Lower-viscosity grades are used in aqueous film-
coating solutions, while higher-viscosity grades are used with organic solvents.  
8. Description 
Hypromellose is an odorless and tasteless, white or creamy-white fibrous or 
granular powder. 
9. Typical Properties 
 Acidity/alkalinity     : pH = 5.5–8.0 for a 1% w/w aqueous solution. 
 Density (bulk)          : 0.341 g/cm3 
 Density (tapped)     : 0.557 g/cm3 
 Density (true)  : 1.326 g/cm3 
 Melting Point   : browns at 190 – 200°C; chars at 225 – 230°C 
                                                Glass transition temperature is 170 - 180o C 
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Table 5.3: Various grades of hypromellose 
Methocelproduct USP 28 designation Nominal viscosity (mPa s)
Methocel K100 Premium LVEP 2208 100 
Methocel K4M Premium 2208 4000 
Methocel K15M Premium 2208 15 000 
Methocel K100M Premium 2208 100 000 
Methocel E4M Premium 2910 4000 
Methocel F50 Premium 2906 50 
Methocel E10M Premium CR 2906 10 000 
Methocel E3 Premium LV 2906 3 
Methocel E6 Premium LV 2906 6 
Methocel E15 Premium LV 2906 15 
Metolose 60SH 2910 50, 4000, 10 000 
Metolose 65SH 2906 50, 400, 1500, 4000 
Metolose 90SH 2208 100, 400, 4000, 15 000 
 
 Solubility 
It is soluble in cold water and forming a viscous colloidal solution, practically 
insoluble inchloroform, ethanol (95%) and ether. But it was soluble in mixtures of 
ethanol and dichloromethane, mixtures of methanol and dichloromethane and 
mixtures of water andalcohol. 
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 Viscosity (dynamic) 
A wide range of viscosity types are commercially available. Aqueous solutions 
are mostcommonly prepared, although hypromellose may also be dissolved in 
aqueous alcohols suchas ethanol and propan-2-ol provided the alcohol content is less 
than 50% w/w. 
10. Stability and Storage Conditions 
Hypromellose powder is a stable material, although it is hygroscopic after drying. 
Solutions are stable at pH 3–11. Increasing temperature reduces the viscosity of solutions. 
Hypromellose undergoes a reversible sol–gel transformation upon heating and cooling, 
respectively.  
11. Incompatibilities 
Hypromellose is incompatible with some oxidizing agents. Since it is nonionic, 
hypromellose will not complex with metallic salts. 
  
MATERIALS AND 
EQUIPMENTS 
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6. MATERIALS AND EQUIPMENTS 
 
6.1. LIST OF RAW MATERIALS 
Table 6.1: List of Raw materials with the name of the Suppliers 
S. No. Name of Raw Material Name of the suppliers 
1 Quetiapine Fumarate 
Astrazeneca Pharmaceutical Private 
Limited, Bangalore. 
2 Sodium alginate(Low viscosity) Qualigens Laboratories, Mumbai. 
3 
Hydroxy propyl methyl 
cellulose(K15M) 
Paraschem suppliers, Pune. 
4 Carbopol-974P Paraschem suppliers, Pune. 
5 Methanol  Qualigens Laboratories, Mumbai. 
6 Calcium chloride Qualigens Laboratories, Mumbai. 
7 Ethanol (95%) Qualigens Laboratories, Mumbai. 
8 Potassium dihydrogen phosphate  SD fine – Chem. Limited, Mumbai 
9 Sodium hydroxide SD fine – Chem. Limited, Mumbai 
10 Peteroleum ether SD fine – Chem. Limited, Mumbai 
 
 
 
Mucoadhesive Microspheres of Quetiapine Materials and Equipments 
 
Adhiparasakthi College of Pharmacy, Melmaruvathur.  Page 70 
 
 
6.2. LIST OF EQUIPMENTS 
 
Table 6.2: List of Equipments with company name 
S. No. Name of the Equipments Company 
1 Electronic Balance Shimadzu, BL-200H, Japan. 
2 UV-Visible Spectrophotometer Shimadzu, 1700, Japan. 
3 FTIR Spectrophotometer Shimadzu –S4008. 
4 
USP, Type II Dissolution Test 
Apparatus 
Veego Scientifics, VDA-
8DR, Mumbai. 
5 
USP Tablet Disintegrating 
apparatus 
Veego Scientifics, VDA-
8DR, Mumbai. 
6 Differential Scanning Calorimeter Schimadu DSC 60, Japan 
7 
Scanning Electron 
Microscopy(SEM) 
SEM -3400     Hitachi, 
Mumbai 
8 Digital pH Meter 
Elico Scientifics-L1 610, 
Mumbai. 
9 Hot air oven 
Prescision Scientific co., P-
1401, Chennai. 
10 Humidity Chamber Labtech, Ambala. 
11 Melting Point Test Apparatus 
Prescision Scientific co., 
Chennai. 
12 Standard sieve Jayant scientific, India. 
 
  
EXPERIMENTAL 
WORK 
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          7. EXPERIMENTAL WORK  
 
7.1. PREFORMULATION STUDY 
 Before formulating a product, the physical and chemical properties of a drug 
substance have undergone some preformulation testing. It is the first step in rational 
development of dosage form. 
7.1.1. Identification of drug 
7.1.1. a) Identification by FTIR spectroscopy          (Skoog D.A., et al., 1996; IP,2007) 
 Quetiapine fumarate discs were prepared by pressing the Quetiapine with 
potassium bromide and the spectra in between 4000 to 500 cm-1 was obtained under the 
operational conditions. The absorption maximums in spectrum obtained with the 
substance being examined correspond in position and relative intensity to those in the 
reference spectrum represented in Table 8.1 and shown in Figure 8.1. 
7.1.1. b) Identificationby melting point                                          (Moffat., et al.,2004) 
 Melting point of the drug was determined by capillary tube method. 
7.1.2. Physicochemical parameters 
7.1.2. a) Organoleptic properties            (Lachman L.,et al.,1991) 
 The color, odor and taste of the drug were recorded using descriptive terminology. 
7.1.2. b) Solubility study                                                         (Moffat., et al.,2004) 
 It is important to know about solubility characteristic of a drug in aqueous system, 
since they must possess some limited aqueous solubility to elicit a therapeutic response. 
The solubility of drug was recorded by using various descriptive terminologies. The 
solubility profile was represented in Table 8.2. 
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7.1.3. Analytical methods 
7.1.3. a) Determination of λ max                            (Swamy P.V., et al., 2007; USP,2009) 
 The absorption maximum of the standard solution was scanned between 200-400 
nm regions on UV-Visible spectrophotometer. The absorption maximum obtained with 
the substance being examined corresponds in position and relative intensity to those in 
the reference spectrum was shown in Figure 8.2. 
7.1.3. b) Development of standard curve of Quetiapine               (IP,1996;USP,2009)               
Preparation of Phosphate buffer (pH 6.8) 
Phosphate buffer (pH 6.8) was prepared according to I.P. 1996. Placed 50 ml of 
0.2 M potassium dihydrogen phosphate in a 200 ml volumetric flask and 22.4 ml of 0.2M 
sodium hydroxide was added and volume was made upto required quantity with water. 
Preparation of 0.2M Potassium dihydrogen phosphate 
Dissolved 27.218 gm of potassium dihydrogen phosphate in water and made up to 
1000 ml.  
Preparation of stock solution of Quetiapine fumarate with pH 6.8 
 Accurately weighed 100 mg of Quetiapine, was dissolved in little quantity of pH 
6.8 and volume was adjusted to 100 ml with the same to prepared standard solution 
having concentration of 30 µg/ml.  
Procedure  
 From the stock solution, aliquots of 1, 2, 3, 4, 5 and 6 ml were transferred into 
100 ml volumetric flasks and final volume was made upto 100 ml with pH 6.8. 
Absorbance values of these solutions were measured against blank (pH 6.8) at 293.5 nm 
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using UV-Visible spectrophotometer. The data was represented in Table 8.3, 8.4 and 
shown in Figure 8.3. 
7.1.3. c) Determination of Percentage purity of Drug                                  (USP, 2009) 
 Accurately weighed 100 mg of Quetiapine was dissolved in little quantity of 
methanol to get the concentration of 1mg/ml. The solution was pipetted out of about 0.5 
ml to 3 ml and volume was made up with distilled water. From the above stock solution, 
the concentration and absorbance was observed. The absorbance was measured at 293.5 
nm against the blank using by UV-Visible spectrophotometer. The percentage purity of 
drug was calculated by using calibration curve method (least square method). The data of 
percentage purity was represented in Table 8.5. 
7.1.4. DRUG EXCIPIENT INTERACTION STUDIES 
7.1.4. a) Determination of drug-polymer compatibility           (Aulton M.E.,et al.,2002) 
The proper design and formulation of a dosage form requires consideration of the 
physical, chemical and biological characteristics of all drug substances and excipients.
 
Figure 7.1: Schematic representation of compatibility studies 
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7.1.4. b) Fourier transform Infra-Red (FTIR) spectroscopy                          (IP, 2007) 
FTIR study was carried out to check compatibility of drug with polymers. Fourier 
transform Infrared Spectrophotometer was determined by using KBr dispersion method. 
The base line correction was done using dried potassium bromide. Then the spectrum of 
dried mixture of Quetiapine and potassium bromide was run followed by Quetiapine with 
various polymers by using FTIR spectrophotometer. The absorption maximums in 
spectrum obtained with the substance being examined correspond in position and relative 
intensity to those in the reference spectrum was represented in Table 8.6 and shown in 
Figure 8.4, 8.5, 8.6 and 8.7. 
7.1.4. c) Differential scanning calorimetry (DSC)                    (AultonM.E., et al.,2002) 
 Any possible drug polymer interaction can be studied by thermal analysis. The 
DSC study was performed on pure Quetiapine, Quetiapine + HPMC K15M, Quetiapine + 
carbopol-974P and Quetiapine + sodium alginate. The 2 mg of sample were heated in a 
hermetically sealed aluminum pans in the temperature range of 25-300ºC at heating rate 
of 10ºC /min under nitrogen flow of 30ml/min. The results of DSC analysis were 
represented in Table 8.7and showed in Figure 8.8, 8.9, 8.10 and 8.11. 
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7.2. METHOD OF PREPARATION OF QUETIAPINE MICROSPHERES 
Table 7.1: Formulation of quetiapine fumarate microspheres 
 
7.2.1. Orifice ionic gelation method (syringes method)          (Swamy P.V., et al., 2007) 
 In this technique cross linking of sodium alginate is done with calcium chloride 
solution to release the drug in a controlled manner. Chemically alginates are anionic 
block co-polymer consisting monomers of d – mannoic acid joined together by 1-4 
glycosidic linkages. Bivalent alkaline earth metals like calcium undergoes ionic 
interaction with COOH moiety of sodium alginate and results are in cross linking of 
sodium alginate. Microspheres were prepared by using the technique in which sodium 
S.No. Batch.No. Drug (g) Sodium 
alginate (%)
HPMC 
K15M (%) 
Carbopol 974 p 
(%) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
QF1 
QF2 
QF3 
QF4 
QF5 
QF6 
QF7 
QF8 
QF9 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1.5 
2.5 
3.5 
1.5 
2.5 
3.5 
1.5 
2.5 
3.5 
- 
- 
- 
2 
2 
2 
- 
- 
- 
- 
- 
- 
- 
- 
- 
1 
1 
1 
M 
A
 
al
ad
m
fo
d
5
so
ro
T
 
 
 
 
 
 
 
ucoadhesiv
dhiparasakth
ginate in di
ded to the a
After 
inutes the d
rm a clear
ispersion wa
0rpm the m
lution then 
om tempera
he flow char
 
 
 
 
 
Figure.7.2
e Microsphe
i College of 
fferent ratio
bove solutio
the aqueou
rug substan
 solution (
s poured in
icrospheres 
were decan
ture. 
t of prepara
  
   
  
   
   
: Preparation
res of Quet
Pharmacy, M
s as mentio
n with cont
s sodium a
ce Quetiapin
polymer –
 15% calciu
thus formed
ted and was
tion of Quet
Sodium
 of microsp
iapine
elmaruvath
ned then ad
inuous stirri
lginate solu
e fumarate 
alginate m
m chloride 
 are allowe
hed with di
iapine micr
 alginate + Q
  Add
Calcium chl
  To f
Microsphere
heres using
ur.
ded mucoad
ng to form h
tion by son
was then ad
ixture). The
solution usi
d 30 min fo
stilled wate
ospheres 
uetiapine+ P
ed  
oride  
orm 
s 
 21# syringe
Experi
hesive poly
omogenous
icating the
ded to the a
 drug poly
ng 22# nee
r curing in 
r and air dr
olymer  
 
 needle in m
mental Wo
Page 7
mers was sl
 solution.  
 mixture fo
bove soluti
mer mixtu
dle by stirri
calcium chl
ied over nig
agnetic stir
rk 
6 
owly 
r 20 
on to 
re is 
ng at 
oride 
ht at 
rer 
Mucoadhesive Microspheres of Quetiapine Experimental Work 
 
Adhiparasakthi College of Pharmacy, Melmaruvathur.  Page 77 
 
7.3. EVALUATION AND CHARACTERIZATION OF MICROSPHERES 
                         (BhabaniNayak S., et al., 2009; Stephen Rathinaraj., et al., 2010) 
Appropriate assessment of a dispersed system requires characterization of both 
chemical and physical stabilities. Physical properties are very important with respect to 
the performance of dispersed systems. 
7.3.1. Particle Size Determination (Subramanayam C. V .S;SwamyP.V,.et al., 2007)
 Particle size distribution for the microspheres were measured by sieving method 
analysis, using set of standard sieves was weighed. Particles having size range between 
50 and 1500 μm are estimated by sieving method. This method directly gives weight 
distribution. The sieving method is a useful application in dosage form development of 
tablets and spheres 
7.3.2. Percentage Yield                        (BhabaniNayak S., et al., 2009) 
  The total amount of microspheres obtained were weighed and evaluated for 
percentage yield.  
        Practical yield  
             Percentage yield =  X 100 
                                             Theoretical yield     
7.3.3. Drug content estimation and Encapsulation efficiency 
                                                          (Swamy P.V, et al., 2007; Dandagi P M., et al.,2004) 
 Quetiapine microspheres (100mg) from each batch were initially stirred in 3 ml 
sodium citrate solution (1%w/v) until complete dissolution. A quantity of 7 ml of 
methanol was added to above solution to solubilise calcium alginate and further solubilise 
Mucoadhesive Microspheres of Quetiapine Experimental Work 
 
Adhiparasakthi College of Pharmacy, Melmaruvathur.  Page 78 
 
the Quetiapine. The filtrate was assayed for drug content by measuring the absorbance at 
293.5 nm after suitable dilution by UV-Visible spectrophotometer and  
Encapsulation efficiency was calculated using the formula, 
     Estimated % drug content in microspheres     
Encapsulation efficiency    =                                                                             × 100 
    Theoretical % drug content in microspheres 
7.3.4. Percentage moisture content:                     (BhabaniNayak S., et al., 2009) 
The Quetiapine loaded microspheres was evaluated to determine the percentage 
moisture content which sharing an idea about its hydrophilic nature. The microspheres 
weighed (w1) initially kept in desicator containing Calcium chloride at 37º C for 24 
hours. The final weight (w2) was noted when no further change in weight of sample was 
observed.  
w1 -   w 2        
Moisture Percentage     =                     × 100 
      w2 
7.3.5. Scanning electron microscopy (SEM):                             (SwamyP.V,.et al.,2007) 
 The microspheres were observed under a Scanning Electron Microscopy. They 
were mounted directly onto SEM sample stub using double-sided sticking tape and 
coated with gold film with ion spillter with gold target with resolution 3 nm (30 KV HV 
Mode),10 nm (30 KV HV Mode), 40 nm (30 LV Mode) and a vacuum system is  fitted to 
it. 
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7.3.6. In -vitro wash off test for mucoadhesion: 
                              (Stephen Rathinaraj., et al., 2010; Mohammed G Ahmed., et al., 2010) 
 The mucoadhesive property of the Quetiapine fumarate microspheres was 
evaluated by an in -vitro adhesion testing method known as the wash – off method. 
Freshly excised pieces of intestinal mucosa (4×5 cm) from sheep were mounted onto 
glass slides (3×1inch) with poly cyanoacrylate glue. Two glass slides were connected 
with a suitable each wet rinsed tissue specimen, and immediately thereafter the support 
were hung onto the arm of a USP tablet disintegrating test machine. When the 
disintegrating test machine was operated, the tissue specimen was given a slow, regular 
up and down movement in the test fluid (400ml) at 37ºC contained in a 1000 ml vessel of 
the machine. At the end of 1 hr and at hourly interval up to 8 hr, the machine was stopped 
and the number of microsphere still adhering to the tissue was counted. The test was 
performed in simulated intestinal fluid (pH6.8 phosphate buffer). 
7.3.7 .In- vitro drug release studies 
          (USP, 2009; SwamyP.V.,et al., 2007;Chowdary K. P. R., et al., 2003) 
  In-vitro drug release study was carried out in USP dissolution test apparatus. A 
quantity of microspheres equivalent to 100 mg of Quetiapine fumarate microspheres was 
kept in basket type apparatus and immersed in 900ml of  phosphate buffer (pH 6.8) in 
1000 ml dissolution flask and temperature was maintained at 37 ± 0.5ºC throughout the 
study. At predetermined time intervals 2 ml of samples was withdrawn by means of a 
syringe fitted with prefilter and same was replaced into the dissolution flask containing 
pH 6.8. The absorbance of sample was measured at 293.5 nm after required dilution with 
the fresh medium (pH6.8).All the studies were conducted in triplicate.  
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7.3.8. Kinetics of In-vitro drug release 
                      (Swamy P.V., et al., 2007; BhabaniNayakS.,et al.,2009) 
 In-vitro drug released data was subjected to in- vitro kinetic models such as zero 
order, first order, Higuchi and Korsemeyer- Peppas. 
¾ Zero order: 
Where    K0 - is the zero-order rate constant expressed in units of concentration/time   
                 t -is the time in hrs. 
¾ First order: 
Where   C0 - is the initial concentration of drug, 
K - is the first order constant 
t - is the time in hrs.  
¾ Higuchi:    Qt = Kt1/2 
Where   Qt - is the amount of the release drug in time t, 
K- is the kinetic constant and t- is time in hrs 
¾ KorsmeyerPeppas: 
Where Mt - represents amount of the released drug at time t,  
M∞- is the overall amount of the drug (whole dose) released after 12 hrs  
K- is the diffusional characteristic of drug/ polymer system constant  
n- is a diffusional exponent that characterizes the mechanism of release of drug.  
 
 
 
 
C = K0t                                                                                                        
Log C = LogC0 – Kt / 2.303                                                                       
Mt/ M∞ = Kt n                                                                                    
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Table 7.2: Diffusion exponent and solute release mechanism 
Diffusion exponent (n) Overall solute diffusion mechanism 
< 0.5 Quasi-Fickian diffusion 
0.5 Fickian diffusion 
0.5 < n < 1.0 Anomalous (non-Fickian) diffusion 
1.0 Case-II transport 
> 1.0 Super case-II transport 
 
7.4. STABILITY STUDY      
(Manavalan R. and Ramasamy S., 2004, Europeon Medicine agency, CPSEA, ICH Q1 A 
(R2) guidelines) 
 In any rational drug design or evaluation of dosage forms, the stability of the 
active component was a major criterion in determining their acceptance or rejection.  
Objective of the study 
 The purpose of stability testing was to provide the evidence on how the quality of 
a drug substance or drug product varies with time under the influence of a variety of 
environmental factors such as temperature, humidity and light, enabling recommended 
storage conditions, re-test periods and shelf-lives. The International Conference on 
Harmonization (ICH) Guidelines titled “Stability testing of New Drug Substances and 
Products describes the stability test requirements for drug registration application in the 
European Union, Japan and the States of America. 
ICH specifies the length of study and storage conditions 
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¾ Long-Term Testing: Room temperature ;25ºC ±2ºC at 60% RH ±5% for 
12 months 
¾ Accelerated Testing: Accelerated temperature ;40ºC ±2ºC at 75% RH 
±5% for 6 Months 
 In present study the optimized formulation F9 was exposured  up to 3 months 
stability studies at accelerated condition (40
º
C ±2
º
C at 75% RH ±5%RH) to find out the 
effect of aging on drug content and In-vitro drug release. 
Procedure 
 The formulation (F9) was stored at accelerated condition in aluminum foils for 3 
months. The samples were withdrawn after end of 1st month, 2nd month and 3rd month. 
The samples were analyzed for its drug content and in vitro drug release. 
  
RESULTS AND 
DISCUSSION 
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8. RESULTS AND DISCUSSION 
 
8.1. PREFORMULATION PARAMETERS 
8.1.1. Identification of drug 
8.1.1. a) Identification by FTIR spectroscopy 
The FTIR spectrum of Quetiapine was shown in Figure 8.1 and the 
interpretations of IR frequencies were represented in Table 8.1. 
 
Figure 8.1: FTIR spectrum of quetiapine 
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¾ Interpretation of FTIR Spectrum 
Major functional groups present in Quetiapine show characteristic peaks in 
FTIR spectrum. The major peaks are identical to functional group of Quetiapine 
Hence, the sample was confirmed as Quetiapine. 
Table 8.1: Characteristic frequencies in FTIR spectrum of quetiapine 
Inference Wave no.(cm-1) 
O-H stretching 3750 
Aromatic C-H stretching 3080 
C-H stretching 2880 
Aromatic C=C stretching 2380 
C-N Stretching 1600 
C-H bending 1340 
C-O-C stretching 1030 
Benzene ring 791 
 
8.1.1. b) Melting point 
Melting point values of Quetiapine sample was found to be in range of 172º C 
to 174º C .The reported melting point for Quetiapine was 1730 C. Hence, experimental 
values were same as official values. 
8.1.2. Physicochemical parameters of drug 
8.1.2. a)Organoleptic properties 
Odour: Odourless 
Colour: White colour 
Nature: crystalline powder  
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8.1.2. b) Solubility study 
Table 8.2: Solubility of quetiapine in various solvents 
 
 
 
 
 
 
 
 
 
 
 
 
8.1.3. Analytical methods 
8.1.3. a) Determination of λ max 
 The absorption maximum for quetiapine was found at 293.5nm  
 
Figure 8.2: λ max observed for quetiapine fumarate in pH 6.8 (phosphate buffer). 
Name of solvent 
Standard Parts of 
solvent required for part 
of solute 
Solubility 
Distilled water From 30 to 100 Slightly Soluble 
0.1N HCl From 30 to 100 Slightly Soluble 
Ethanol (95%) From 1 to 30 Highly soluble 
Methanol From 1 to 30 Highly Soluble 
Isopropyl alcohol More than 10000 Partially insoluble 
Glacial acetic acid More than 10000 Partially insoluble 
Acetone More than 10000 Partially insoluble 
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8.1.3. b) Preparation of standard graph of Quetiapine fumarate 
 UV absorption spectrum of Quetiapine fumarate in phosphate buffer (pH 6.8) 
showed λ max at 293.5 nm. Absorbance obtained for various concentrations of 
Quetiapine fumarate in pH 6.8 were represented in Table 8.3. The graph of 
absorbance vs. concentration for Quetiapine fumarate was found to be linear in the 
concentration range of 5–30 μg/ml. The drug obeys Beer- Lambert’s law in the range 
of 5–30 μg /ml. 
Table 8.3: Data of concentration and absorbance for quetiapine fumarate  
     in pH 6.8 buffer 
S.No. 
Concentration 
(µg/ml) 
Absorbance 
1 0 0.000 
2 5 0.097 
3 10 0.189 
4 15 0.291 
5 20 0.387 
6 25 0.483 
7 30 0.587 
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Figure 8.3: Standard curve for quetiapine fumarate in pH 6.8 (phosphate  
        buffer)    
 
Table 8.4: Data for calibration curve parameters 
S. No. Parameters Values 
1 Correlation coefficient (r) 0.9999 
2 Slope 0.019507 
3 Intercept -0.00204 
 
8.1.3. c) Percentage purity of drug 
The percentage purity of drug was calculated by using calibration graph 
method (least square method). 
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Table 8.5: Data of percentage purity of drug 
  
 
 
 
 
 
The reported percentage purity for Quetiapine fumarate in USP is 98 to 102%. 
8.1.4. Determination of compatibility for drug with polymer 
8.1.4. a)  FTIR spectroscopy 
 
Figure 8.4: FTIR spectrum of quetiapine 
S. No. Percentage purity (%) Avg. percentage purity (%) 
1 99.71 
 
100.4 
2 100.51 
3 101.10 
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Figure 8.5: FTIR spectrum of Quetiapine with Sodium alginate 
 
Figure 8.6: FTIR spectrum of quetiapine with HPMC K15M 
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Figure 8.7: FTIR spectrum of quetiapine with carbopol 974p 
Table 8.6: The major peak observed in FTIR spectrum of quetiapine and quetiapine  
      with different polymers used in formulations. 
Wave 
No. 
(cm-1) 
Functional 
group 
Peak observed (Yes/No) 
Quetiapine
Quetiapine+ 
Sodiumalginate 
Quetiapine+ 
HPMC K15M 
Quetiapine+ 
Carbopol974p
3750 
O-H 
stretching Yes Yes Yes Yes 
3080 
Aromatic C-H 
stretching Yes Yes Yes Yes 
2880 
C-H 
stretching Yes Yes Yes Yes 
2380 
Aromatic 
C=C 
stretching 
Yes Yes Yes Yes 
1600 
C-N 
Stretching Yes Yes Yes Yes 
1340 C-H bending Yes Yes Yes Yes 
1030 
C-O-C 
stretching Yes Yes Yes Yes 
791 Benzene ring Yes Yes Yes Yes 
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 The major peaks of Quetiapine fumarate spectrum were compared to 
Quetiapine fumarate with polymers spectrum. There was no interaction between 
Quetiapine fumarate and polymers. The data was represented in Table 8.6 and shown 
in Figure 8.4, 8.5, 8.6 and 8.7. 
8.1.4. b) DSC thermal analysis: The interactions between Quetiapine and polymers 
were determined by DSC studies and results were represented in Table 8.7 and shown 
Figure 8.8, 8.9, 8.10 and 8.11. 
 
Figure 8.8: DSC thermogram for quetiapine fumarate 
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Figure 8.9: DSC thermogram for quetiapine fumarate with Sodium alginate 
 
 
Figure 8.10: DSC thermogram for quetiapine fumarate with HPMC K15M 
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Figure.8.11: DSC thermogram for quetiapine fumarate with carbopol 974P 
 
Table 8.7: Various DSC thermogram parameter 
S. No. DSC Graphs 
Peak 
( ºC ) 
Onset 
temperature 
( ºC ) 
Endset 
temperature
( ºC ) 
1 Quetiapine fumarate 173.70 161.80 177.38 
2 Quetiapine + sodium alginate 175.38 163.30 181.81 
3 Quetiapine + HPMC k15M 170.83 159.01 187.93 
4 Quetiapine + carbopol 974p 175.19 167.63 190.01 
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8.2. EVALUATION OF QUETIAPINE LOADED MUCOADHESIVE 
MICROSPHERES 
¾ Percentage yield 
¾ Size analysis 
¾ Drug content estimation and Encapsulation efficiency 
¾ Percentage moisture content 
¾ Scanning electron microscopy 
¾ In vitro wash –off test for mucoadhesion 
¾ In vitro drug release studies 
8.2.1. Percentage yield 
 The total amount of microspheres obtained were weighed and evaluated for 
percentage yield and represented in Table 8.8 .From this, formulation F8 showed 
maximum percentage yield among the formulations prepared. 
Table 8.8: Percentage yield of all microspheres formulations 
S. No Formulation Code Percentage yield (%) 
1. F1 75.19 
2 F2 77.40 
3 F3 73.20 
4 F4 82.20 
5 F5 82.00 
6 F6 71.60 
7 F7 65.60 
8 F8 87.95 
9 F9 88.65 
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8.2.2. Particle size determinations 
 Average particle size of microspheres was determined for all the formulations 
by sieving method analysis by using standard sieves. All the values were represented 
in Table 8.9. From the values, the formulation F9 had given the less average particle 
size compared to all other formulation 
Table 8.9: Average particle size of microspheres 
S. No Formulations Average particle size (µm) 
1 F1 602.28 
2 F2 650.18 
3 F3 770.74 
4 F4 708.268 
5 F5 740.578 
6 F6 784.506 
7 F7 650.85 
8 F8 680.31 
9 F9 754.34 
 
8.2.3. Drug content estimation and encapsulation efficiency 
  Quetiapine microspheres (100 mg) from each batch were initially stirred in 3 
ml sodium citrate solution (1%w/v) until it completely dissolves .A quantity of 
methanol 7ml was added to above solution to gel solubilise calcium alginate and 
further  solubilise Quetiapine. The filtrate was assayed for drug content by measuring 
the absorbance at 293.5 nm after suitable dilution. Encapsulation efficiency was 
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calculated using the formula. The drug content of microspheres were calculated for all 
the formulations (F1 to F9) and represented in Table 8.10 also shown in Figure 
8.14.The formulation F9 was showed maximum drug  content among the formulations 
were prepared 
     Estimated % drug content in microspheres 
Encapsulation efficiency     =                       ×100 
                         Theoretical % drug content in microspheres 
 
Table 8.10: Drug content of all microspheres formulations 
S. No Formulations
Mean drug 
content 
(%) ± S.D∗ 
Entrapment 
efficiency 
(%) 
1 F1 31.210 ± 0.039 63.42 
2 F2 40.120± 0.058 79.25 
3 F3 42.476± 0.045 83.95 
4 F4 40.418± 0.014 81.83 
5 F5 41.990± 0.018 82.90 
6 F6 42.770± 0.051 85.54 
7 F7 35.610±0.063 70.22 
8 F8 34.730±0.004 68.46 
9 F9 43.96± 0.085 87.70 
*All values are expressed as mean ± S.D. n=3 
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Table 8.11: Percentage moisture content of microspheres 
 
S. No 
 
Formulations 
 
 
Percentage moisture 
content 
(% ± S.D) 
 
1 F1  8.273±0.155 
2 F2  6.837± 0.078 
3 F3  4.876± 0.090 
4 F4  3.258± 0.141 
5 F5  2.529± 0.050 
6 F6  1.838± 0.063 
7 F7  2.516±0.040 
8 F8  1.244±0.130 
9 F9 1.116±0.130 
*All values are expressed as mean ± S.D. n=3 
 By comparing all the values of all formulations, formulation F9 was found to 
be the best one. The formulation F9 showed less moisture content. The order was 
F9<F8<F6<F7<F5<F4<F3<F2<F1. 
8.2.5. Scanning electron microscopy (SEM) 
 The microspheres were observed under a scanning electron microscopy. The 
resolution of SEM instrument was 3 nm (30 KV HV Mode), 10 nm (30 KV HV 
Mode), 40 nm (30 LV Mode) and a vacuum system is fitted to it. The shape of the 
Quetiapine microspheres was evidenced from the Scanning Electron microscopy was 
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found to be spherical and uniformly distributed and was shown in Figure 8.15 and 
8.16. 
 
Figure 8.15: Scanning electron microscopy of drug loaded sodium alginate  
          carbopol 974P 
 
Figure 8.16: Scanning electron microscopy of formulation F9.  
8.2.6. In vitro wash off test for mucoadhesion 
 The wash off test for mucoadhesion for all formulations (F1 to F9) were 
represented in Table 8.12 and graphically shown in Figure 8.17. 
Mucoadhesive Microspheres of Quetiapine Results and Discussion
 
Adhiparasakthi College of Pharmacy, Melmaruvathur.  Page 101 
 
 The mucoadhesive wash off test was showed in the order of 
F1<F6<F4<F2<F3<F5<F7<F8<F9. Low values of standard deviation indicate good 
mucoadhesion in each batch of microspheres. 
 
Table 8.12: Data of in- vitro wash off test to assess mucoadhesive properties of  
    microspheres 
% of Microspheres adhering to the tissue at various time interval* in 8 hours 
Formulations pH  1(hr) 2(hr) 4(hr) 6(hr) 8(hr) 
F1 6.8 97.8±0.1 89.9±0.6 86.2±0.9 59.4±0.6 41.7±1.6 
F2 6.8 97.3 ±0.9 90.3±0.9 87.6±2.0 60.5±1.2 44.5±2.0 
F3 6.8 96±1.07 91±0 87±2.0 72.3±1.2 52.3±1.8 
F4 6.8 98±2.0 95.6±1.2 85.3±3.3 79±2.0 43.6±2.2 
F5 6.8 98±2.1 95.2±1.2 90.5±2.0 78.7±1.9 55.2±1.5 
F6 6.8 98.6±2.0 96.6±1.2 92.6±1.2 72.9±1.2 42.1±1.5 
F7 6.8 98.4±2.0 97±1.2 90.3±2.0 62.9±1.2 59.5±3.5 
F8 6.8 99± 1.3 97±0 91.6±1.2 79.9±1.9 61.3±1.2 
F9 6.8 100±0 97.3±0.9 92.6±2.0 84.2±3.1 64.9±1.2 
 
*All values are expressed as mean ± S.D. n=3 
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8.2.7. In vitro drug release studies  
Table.8.13: Results of in vitro release studies of quetiapine loaded mucoadhesive     
                    microspheres* at 12 hours 
S. No 
Time 
in 
hours 
Formulation code 
F1 F2 F3 F4 F5 F6 F7 F8 F9 
1 1 
10.92
±0.11 
10.06
±1.54 
9.07±
1.04 
10.24±
1.54 
9.65±
1.56 
10.48±
0.45 
10.48
±2.78 
9.81±
0.45 
8.36±
1.54 
2 2 
22.35
±1.23 
21.78
±1.89 
19.75
±2.66 
21.81±
0.61 
20.18
±1.05 
18.96±
0.15 
18.45 
±1.96 
17.73
±0.55 
15.88
±1.45 
3 3 
28.39
±2.54 
28.49
±2.54 
26.29
±0.20 
29.93±
0.02 
28.5±
3.51 
27.96±
1.63 
27.96
±0.12 
24.11
±0.56 
22.18
±1.52 
4 4 
40.59
±1.56 
36.28
±1.65 
35.97
±1.53 
41.92±
0.91 
40.22
±1.55 
31.18±
3.55 
31.18
±0.56 
30.02
±0.22 
29.39
±0.01 
5 5 
43.29
±2.57 
42.36
±0.22 
40.49
±2.01 
48.76±
0.78 
45.49
±0.45 
39.26±
2.23 
39.26
±1.56 
37.9±
1.51 
35.48
±0.12 
6 6 
55.82
±0.23 
55.48
±2.55 
51.29
±2.50 
55.25±
0.51 
52.06
±0.61 
48.38±
1.25 
48.38
±3.45 
47.66
±1.02 
40.19
±0.65 
7 7 
63.92
±1.54 
57.39
±0.23 
58.39
±1.21 
59.38±
0.05 
57.19
±0.49 
51.9±0
.61 
51.9±
1.56 
50.04
±2.55 
48.99
±0.54 
8 8 
69.94
±2.45 
68.39
±2.55 
62.01
±0.54 
70.69±
0.07 
68.24
±0.61 
62.01±
0.74 
62.01
±1.26 
58.46
±2.16 
55.38
±1.55 
9 9 
74.26
±2.77 
71.01
±2.54 
69.45
±0.26 
75.2±0
.48 
74.39
±1.54 
65.33±
0.07 
65.33
±0.16 
62.09
±2.55 
61.47
±0.65 
10 10 
87.28
±2.54 
90.37
±2.54 
81.92
±0.50 
82.19±
0.52 
80.27
±0.91 
81.53±
0.21 
81.53
±1.51 
82.19
±2.16 
71.24
±0.55 
11 11 
90.22
±3.45 
95.2±
2.56 
93.28
±0.78 
88.36±
0.46 
86.33
±0.61 
84.74±
0.51 
84.74
±2.51 
86.28
±2.55 
76.92
±1.56 
12 12 
98.36
±0.54 
97.62
±0.59 
97.04
±0.49 
96.35±
0.65 
95.14
±0.61 
92.37±
0.45 
90.37
±0.54 
85.37
±2.15 
79.3±
1.56 
 
*All values are expressed as mean ± S.D. n=3 
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¾ Dissolution profile of formulation F1 
 
Figure 8.18 : In vitro released graph of formulation F1 
 
¾ Dissolution profile of formulation F2 
 
 
Figure 8.19: In vitro released graph of formulation F2 
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¾ Dissolution profile of formulation F3 
 
 
Figure.8.20: In vitro released graph of formulation F3 
 
¾ Dissolution profile of formulation F4 
 
Figure 8.21: In vitro released graph of formulation F4 
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¾ Dissolution profile of formulation F5 
 
 
Figure 8.22: In vitro released graph of formulation F5 
 
¾ Dissolution profile of formulation F6 
 
Figure 8.23 : In vitro released graph of formulation F6 
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¾ Dissolution profile of formulation F7 
 
Figure 8.24 : In vitro released graph of formulation F7 
 
¾ Dissolution profile of formulation F8 
 
 
 
Figure 8.25: In vitro released graph of formulation F8 
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¾ Dissolution profile of formulation F9 
 
Figure 8.26: In vitro released graph of formulation F9 
 
 
¾ Dissolution profile of formulation F1-F9 
 
Figure 8.27 : Comparision of in- vitro drug released for formulations F1 to F9 
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From the in vitro drug released studies the formulations F1 - 98.36%, F2 -
97.62%, F3 - 97.04%, F4 - 96.35%, F5 - 95.14%, F6 - 92.37%, F7 - 90.37%, F8 - 
85.37% and F9 - 79.30% were released the drug up to 12 hours. 
 Based upon the in vitro drug released profile the formulations F9 was chosen 
as best one among the formulations F1 to F9 were prepared. The formulation F9 
released drug in sustained manner up to 12 hours compared other formulations 
Table 8.14: Data of the percentage drug released at t25%, t50%, and t90% values 
 
 
 
 
 
 
 
 
 
 
 
 
 
S. No 
 
Formulations 
Time of % drug release(hours) 
 t25%  t50%   t90% 
1 F 1 2.8 5.8 8.3 
2 F 2 2.5 6.1 8.9 
3 F 3 2.9 5.5 7.7 
4 F 4 2.9 6.1 8.5 
5 F 5 3.1 5.7 9.3 
6 F 6 3.2 5.3 8.9 
7 F 7 3.1 5.2 11.8 
8 F 8 2.9 5.7 13.5 
9 F9 3.1 5.9 13.7 
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Figure 8.28: Comparision of in vitro drug released with t25%,t50%,t90% values 
8.2.7. Kinetics of Drug release 
                The kinetics of In-vitro drug release was determined by applying the drug 
released data to various kinetic models such as zero order, first order, Higuchi and 
Korsmeyer- Peppas. The result obtained was represented in Table 8.22 and shown in 
Figure 8.29, 8.30, 8.31, 8.32, 8.33, 8.34, 8.35, 8.36 and 8.37. 
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Table 8.15:  In vitro drug released kinetics studies of all formulations 
Formulation 
code 
Zero 
order 
R2 
First 
order 
R2 
Higuchi 
R2 
Korresmayer Peppas 
Best fit 
model 
R2 n 
F1 0.992 0.752 0.947 0.995 0.4539 Peppas 
F2 0.990 0.766 0.928 0.993 0.4437 Peppas 
F3 0.994 0.752 0.925 0.995 0.5002 Peppas 
F4 0.989 0.832 0.958 0.993 0.4771 Peppas 
F5 0.992 0.894 0.951 0.995 0.4226 Peppas 
F6 0.993 0.872 0.928 0.994 0.4588 Peppas 
F7 0.993 0.872 0.928 0.994 0.3744 Peppas 
F8 0.988 0.841 0.909 0.991 0.3481 Peppas 
F9 0.997 0.939 0.930 0.998 0.3475 Peppas 
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Figure 8.29: The best fit model (Peppas) of formulation F1 
 
Figure 8.30: The best fit model (Peppas) of formulation F2 
 
Figure 8.31: The best fit model (Peppas) of formulation F3 
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Figure 8.32: The best fit model (Peppas) of formulation F4 
 
Figure 8.33: The best fit model (Peppas) of formulation F5 
 
Figure 8.34: The best fit model (Peppas) of formulation F6 
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Figure 8.35: The best fit model (Peppas) of formulation F7 
 
Figure 8.36: The best fit model (Peppas) of formulation F8 
 
Figure 8.37: The best fit model (Peppas) of formulation F9 
 The drug released from the microspheres was diffusion controlled. The 
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a linear (r>0.99).  The drug released profile of formulations, was shown by Fickian 
diffusion mechanism (n<0.5) and the best fit model was Korsmeyer-Peppas model. 
8.3. STABILITY STUDY 
 The formulation F8 was observed after specified period stability studies as per 
ICH guidelines .The formulations was monitored for drug content and In-Vitro drug 
released profile and results were represented in Table 8.23 and percentage drug 
released profile was shown in Figure 8.38. 
                  Table 8.16: Data of stability studies of formulation (F9) 
Characteristics Initials* 1 month* 2 month* 3 month* 
Drug content (%) 
43.730±0.15 43.454±0.18 42.454±0.038 41.848±0.07 
In-vitro drug release 
for 12 hours 
78.983±0.15 78.576±0.25 77.327±0.04 77.271±0.05 
*All the values are expressed as mean± S.D., n=3 
 
Figure 8.38: Cumulative % drug released after stability studies 
There was no major difference found between before and after stability studies. 
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9. SUMMARY AND CONCLUSION 
 
 The goal of any drug delivery system was to provide the therapeutic amount of 
drug to the proper site in the body also to achieve and maintain the desired drug 
concentration in blood. Improving the therapeutic efficacy of existing drugs has been 
tried by different technologies. One of the effective technologies exiting in recent years 
of pharmacy is Microspheres. 
 Mucoadhesive drug delivery system was developed in pharmacy field and drug 
retention for a prolonged time has been achieved. Hence, it was made an effective 
attempt to formulate the mucoadhesive microspheres by using Quetiapine fumarate as the 
model drug it possess the mean half life of six hours and bioavailability was found to be 
only 9%. Hence, it was chosen as the good candidate for the mucoadhesive microspheres 
in order to improve the bioavailability and prolong period of drug released. 
 The identification of the drug was done by the FTIR spectroscopy analysis and 
drug polymers interaction was studied by DSC studies. It was concluded that no 
interaction was found between the Quetiapine fumarate and polymers.  
 Mucoadhesive microspheres of Quetiapine fumarate were prepared by Orifice-
ionic gelation method. Drug-loaded mucoadhesive microspheres   were composed of 
sodium alginate alone and in combination with HPMC K15M and carbopol 974p. For 
first three formulations F1, F2, F3 sodium alginate alone and F4, F5, F6 were composed 
of sodium alginate and HPMC K15M and F7, F8, F9 were composed of sodium alginate 
and carbopol 974p. From these formulations were evaluated for the particle size, 
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percentage yield, drug content and encapsulation efficiency, percentage moisture content, 
SEM analysis, in vitro wash off test, in vitro drug released, and stability studies. 
 The higher incorporation efficiency was observed as the concentration of alginate 
increased. This may be attributed to the greater availability of active calcium-binding 
sites in the polymeric chains and consequently the greater degree of cross linking as the 
quantity of sodium alginate increased, resulting in the formation of nonporous 
microspheres. The drug loading efficiency greatly improved when alginate was blended 
with carbopol at 1% level. 
Mucoadhesive property of microspheres consisting of sodium alginate alone and 
in combination with HPMC K15M and carbopol 974p exhibited good mucoadhesive 
properties as. The wash-off was faster at simulated intestinal pH (6.8) than that at 
simulated gastric pH. Finally, reported that the solubility, hydration and mucoadhesivity 
of the polymers depend on the pH of the medium. The rapid wash-off observed at 
simulated intestinal pH may be due to the ionization of carboxyl acid group and other 
functional groups in the polymers, which increase their solubility and reduce adhesive 
strength. It would ensure the pro-long residence time at the absorption site to facilitate 
intimate contact with the absorption surface and thereby improve and enhance the 
bioavailability.  
 The in vitro drug release studies were carried out in the simulated intestinal fluid 
phosphate buffer pH (6.8). The microspheres were prepared by ionic internal gelation 
technique using calcium chloride as cross-linking agent. The microspheres cross-linked 
with calcium showed delay in disintegration and consequently a slow release of drug was 
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obtained. To retard or sustain the drug release from the microspheres, HPMC K15M and 
carbopol 934P were blended with the alginate matrix. 
 This kind of release is the characteristics of swelling-controlled system in which 
the rate of solvent uptake into a polymer is largely determined by the rate of swelling and 
relax-ation of the polymer chains. It is assumed that the drug molecules diffuse out 
through a dissolving gel-like layer formed around the drug during the dissolving process.  
 On comparing the major criteria in evaluation such as drug content, encapsulation 
efficiency, in vitro wash off test and in vitro drug release characteristics, the formulation 
F9 was selected as the best formulation, as it showed the drug content as 43.96% and 
encapsulation efficiency was 87.70%, showed a good mucoadhesive nature in the in vitro 
wash off test was nearly 64.9% upto 8 hrs and     in vitro drug released upto 12 hrs. Based 
on all the above evaluation parameters it was concluded that the formulation F9 was 
found to be best formulation among the formulations from F1 to F9. The mechanism of 
drug released was calculated by applying the kinetic models and it was concluded that the 
formulations F9 follows the Korsmeyer – Peppas model and it undergoes Fickian 
diffusion mechanism (n≥0.5). 
According to the stability studies, the formulation F9 was found to be stable upto 
3 months of storage period in drug content and in vitro drug released profile. 
 The formulations F9 was concluded best formulation among the formulations 
were prepared.  
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10. FUTURE PROSPECTS 
  
In this present work, physio-chemical characterization and in vitro evaluation of 
Quetiapine fumarate Mucoadhesive microspheres were performed. 
The following work had to perform in future: 
 The microspheres can be also formulated by using other different mucoadhesive 
polymers. 
 The mucoadhesive microspheres can also be formulated for advanced drug 
delivery other than oral administration. 
 In vivo and in vitro correlation studies had yet to be performed and the results has 
to be determined .From the correlation results, it can serve as the model for 
humans and gain a better understanding of drug absorption and its dependence in 
vitro drug release. 
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